0001401914-21-000017.txt : 20210111 0001401914-21-000017.hdr.sgml : 20210111 20210111074540 ACCESSION NUMBER: 0001401914-21-000017 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20210111 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36395 FILM NUMBER: 21519167 BUSINESS ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-926-7655 MAIL ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 8-K 1 dare8-k01112021.htm 8-K Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 11, 2021
DARÉ BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)
 
Delaware 001-36395 20-4139823
(State or other jurisdiction
of incorporation)		 (Commission
File Number)		 (I.R.S. Employer
Identification No.)
 
3655 Nobel Drive, Suite 260
San Diego, CA 92122
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: (858) 926-7655
 
Not Applicable
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
   
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stockDARENasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨


Item 8.01Other Events
Included as Exhibit 99.1 to this report is a presentation about Daré and its product candidates, dated January 11, 2021, which is incorporated herein by reference. Daré intends to use the presentation and its contents in various meetings with investors, securities analysts and others, commencing on January 11, 2021.


Item 9.01Financial Statements and Exhibits.
(d) Exhibits.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  
DARÉ BIOSCIENCE, INC.
 
Dated: January 11, 2021  By: /s/ Sabrina Martucci Johnson
  Name: Sabrina Martucci Johnson
  Title: President and Chief Executive Officer

 EX-99.1 2 darecorporatepresentatio.htm EX-99.1 darecorporatepresentatio
User-Controlled Long-Acting Reversible Contraception ©2021 Daré Bioscience | All rights reserved NASDAQ: DARE www.darebioscience.com Corporate Presentation: January 11, 2021 Daré Bioscience Exhibit 99.1

 
Forward-Looking Statements; Disclaimers 2 THIS PRESENTATION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITIES OF DARÉ BIOSCIENCE, INC. (“DARÉ” OR THE “COMPANY”). THIS PRESENTATION INCLUDES CERTAIN INFORMATION OBTAINED FROM TRADE AND STATISTICAL SERVICES, THIRD PARTY PUBLICATIONS, AND OTHER SOURCES. DARÉ HAS NOT INDEPENDENTLY VERIFIED SUCH INFORMATION AND THERE CAN BE NO ASSURANCE AS TO ITS ACCURACY. ALL STATEMENTS IN THIS PRESENTATION, OTHER THAN STATEMENTS OF HISTORICAL FACT, ARE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF FEDERAL SECURITIES LAWS. IN SOME CASES, YOU CAN IDENTIFY FORWARD-LOOKING STATEMENTS BY TERMS SUCH AS “MAY,” ”WILL,” “EXPECT,” “PLAN,” “ANTICIPATE,” “STRATEGY,” “DESIGNED,” “COULD,” “INTEND,” “BELIEVE,” “ESTIMATE,” “TARGET,” OR “POTENTIAL” AND OTHER SIMILAR EXPRESSIONS, OR THE NEGATIVE OF THESE TERMS. AS USED IN THIS PRESENTATION, “FIRST-IN- CATEGORY” IS A FORWARD-LOOKING STATEMENT REGARDING MARKET POTENTIAL OF A PRODUCT CANDIDATE. FORWARD-LOOKING STATEMENTS INVOLVE RISKS, UNCERTAINTIES AND ASSUMPTIONS THAT MAY CAUSE DARÉ’S ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS TO BE MATERIALLY DIFFERENT FROM THOSE EXPRESSED OR IMPLIED BY THE FORWARD-LOOKING STATEMENTS, INCLUDING, WITHOUT LIMITATION RISKS AND UNCERTAINTIES RELATING TO: THE OUTCOME OR SUCCESS OF CLINICAL TRIALS; DARÉ’S ABILITY TO RAISE ADDITIONAL CAPITAL AS NEEDED; DARÉ’S ABILITY TO OBTAIN AND MAINTAIN INTELLECTUAL PROPERTY PROTECTION FOR ITS PRODUCT CANDIDATES; DARÉ’S ABILITY TO DEVELOP AND OBTAIN REGULATORY APPROVAL OF PRODUCT CANDIDATES ON THE TIMELINES SET FORTH HEREIN; INCLUDING DUE TO THE EFFECT, IF ANY, THAT COVID-19 MAY HAVE THEREON; AND OTHER RISK FACTORS DESCRIBED IN DARÉ’S MOST RECENT ANNUAL REPORT ON FORM 10-K AND QUARTERLY REPORT ON FORM 10-Q FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. ALL FORWARD-LOOKING STATEMENTS IN THIS PRESENTATION ARE CURRENT ONLY AS OF THE DATE HEREOF AND DARÉ DOES NOT UNDERTAKE ANY OBLIGATION TO UPDATE ANY FORWARD-LOOKING STATEMENT TO REFLECT NEW INFORMATION, FUTURE DEVELOPMENTS OR OTHERWISE, EXCEPT AS REQUIRED BY LAW. ALL TRADEMARKS, SERVICE MARKS OR TRADE NAMES APPEARING IN THIS PRESENTATION ARE THE PROPERTY OF THEIR RESPECTIVE OWNERS. UNLESS SPECIFICALLY IDENTIFIED AS SUCH, DARÉ’S USE OR DISPLAY OF THIRD-PARTY MARKS IS NOT INTENDED AND DOES NOT INDICATE OR IMPLY ANY RELATIONSHIP WITH OR ENDORSEMENT OR SPONSORSHIP OF DARÉ BY THE THIRD-PARTY OWNER.

 
Daré Bioscience - A Compelling Opportunity 3 Daré Bioscience is a clinical-stage biopharmaceutical company committed to advancing innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility. Company Highlights ✓ June 2019 – Positive findings of Sildenafil Cream, 3.6% thermography clinical study ✓ Nov. 2019 – Positive topline data for Ovaprene® postcoital test clinical study ✓ Jan. 2020 – Exclusive licensing agreement with Bayer for Ovaprene ✓ May/Sept 2020 – Strategic partnerships with Health Decisions / Avomeen ✓ Sept. 2020 – Bill & Melinda Gates Foundation grant funding for DARE-LARC1 reaches $20.5 million ✓ Dec. 2020 – Positive topline data for DARE-BV1 Phase 3 study Anticipated Clinical & Regulatory Milestones* 2021  NDA submission to FDA for DARE-BV1  Topline data for DARE-HRT1 Phase 1 study  PDUFA date for DARE-BV1^  Topline data for Sildenafil Cream, 3.6% for FSAD Phase 2b study 2022  U.S. commercial launch of DARE-BV1  Topline data for Ovaprene pivotal contraceptive effectiveness study * Timeline reflects management’s current estimates and constitutes a forward-looking statement subject to qualifications noted elsewhere in this presentation. ^ Would require a priority review designation from the FDA. DARE-BV1 has Fast Track and Qualified Infectious Disease Product designations from the FDA for treatment of bacterial vaginosis.

 
Women’s Health Is Our Sole Focus 4 Working to accelerate innovative product options in women’s health by… • Identifying and advancing new therapies that provide additional choices • Enhancing outcomes • Improving ease of use We look for… • Differentiated investigational products with attractive market opportunities + unmet medical needs • Proof-of-concept and/or ability to leverage a 505(b)(2) regulatory pathway • First-in-category or first-line opportunities • Personalized for women (non-systemic delivery)

 
Partnering to Accelerate Innovation 5 * We partner to… Accelerate exciting new products Develop new solutions to address persistent unmet needs Become a pipeline resource for large and emerging commercial companies Drive innovation We partner with…

 
Advancing Products Women Want 6 Potential First-line Option for Bacterial Vaginosis Bioadhesive gel, clindamycin 2% First-in-category Hormone-Free Monthly Contraception Monthly, self-administered drug/device barrier IVR, DARE-BV1^ Bacterial Vaginosis- Phase 3 Topline Data Announced December 2020 Ovaprene® Hormone-Free, Monthly Contraception- Pivotal Study 3 Topline Data 2022* First-in-category treatment for Female Sexual Arousal Disorder (FSAD) Topical Cream, same active ingredient as Viagra® Sildenafil Cream, 3.6% ^ Female Sexual Arousal Disorder-Phase 2b Topline Data 2021* PARTNERS Product Candidate PRE-CLINICAL PHASE 1 PHASE 2 PHASE 3 / PIVOTAL REGULATORY FILING * Timeline reflects management’s current estimates and constitutes a forward-looking statement subject to qualifications noted elsewhere in this presentation. Actual development timelines may be substantially longer, and Daré is under no obligation to update or review these estimates. “First-in- category” statements are forward-looking statements relating to market potential of Daré’s product candidates based on currently available, FDA-approved therapies. ^505(b)(2) regulatory pathway anticipated.

 
Near Term Catalysts to Drive Value 7 DARE-BV1^ Bacterial Vaginosis Phase 3 Completed Sildenafil Cream, 3.6%^ FSAD Phase 2b Topline Data Ovaprene® Contraception Pivotal Topline Data 2020 2021 2022 DARE-HRT1^‡ Hormone Replacement Therapy Phase 1 Topline Data Planned NDA Submission & FDA Review Accelerating innovation in women’s health DARE-BV1 NDA filing and two top-line data readouts expected during 2021. Timeline reflects management’s current estimates and constitutes a forward-looking statement subject to qualifications noted elsewhere in this presentation. Actual development timelines may be substantially longer, and Daré is under no obligation to update or review these estimates. “First-in- category” statements are forward-looking statements relating to market potential of Daré’s product candidates based on currently available, FDA-approved therapies. ^505(b)(2) regulatory pathway anticipated. ‡DARE-HRT1 Phase 1 study being conducted in Australia by Daré subsidiary.

 
Experienced Management & Board of Directors 8 Board of Directors William Rastetter, PhD Chairman Cheryl Blanchard, PhD Jessica Grossman, MD Susan Kelley, MD Greg Matz, CPA Robin Steele, JD, LLM Sabrina Martucci Johnson MSc, MIM President & CEO Management Team Sabrina Martucci Johnson MSc, MIM President & CEO John Fair Chief Strategy Officer Lisa Walters-Hoffert Chief Financial Officer David Friend, PhD Chief Scientific Officer Mary Jarosz, RPh, RAC, FTOPRA Global Head of Regulatory Affairs Mark Walters Vice President of Operations Christine Mauck, MD, MPH Medical Director We are delivering innovation by daring to be different®

 
DARE-BV1 Clindamycin 2% gel for Bacterial Vaginosis Best-in-class curative potential for the most common1 vaginal infection in women of reproductive age, designed for convenient, one-time administration Expect pre-NDA meeting with FDA early 2021, planned NDA submission 1H 2021 91. https://www.cdc.gov/std/bv/stats.htm

 
Bacterial Vaginosis - What Is the clinical issue? Recurring infection, difficult to treat effectively • Most common vaginal infection in women ages 15-44, affecting ~21 million women in the US1 • Current Rx suboptimal: clinical cure rates of 37-68%2 Bacterial Vaginosis increases health risk3 • Preterm birth – bacterial vaginosis is linked to premature deliveries, low birth weight babies • Sexually transmitted infections – bacterial vaginosis increases susceptibility to HIV, herpes simplex virus, chlamydia, gonorrhea • Post-surgical infection – bacterial vaginosis may increase risk of infection after gynecologic procedures • Pelvic inflammatory disease – bacterial vaginosis may cause PID, an infection that affects women’s reproductive organs and can increase the risk of infertility 101. https://www.cdc.gov/std/bv/stats.htm 2. Bacterial vaginosis product data: http://www.clindesse.com/pdf/PI.pdf; http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205223s000lbl.pdf; http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205223s000lbl.pdf 3. https://www.mayoclinic.org/diseases-conditions/bacterial-vaginosis/symptoms-causes/syc-20352279

 
11 DARE-BV1: Potential for Improved Clinical Cure Rates vs. Current Branded Rx 1. Data on file 2. SOLOSEC PRESCRIBING INFORMATION https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=551e43d5-f700-4d6e-8029-026f8a8932ff&type=display 3. Clindesse PRESCRIBING INFORMATION https://www.clindesse.com/pdf/PI.pdf 4. Nuvessa PRESCRIBING INFORMATION https://www.nuvessa.com/nuvessa_files/Nuvessa%20PI%202018-08.pdf

 
DARE-BV1: Looking Forward DARE-BV1 delivered better clinical cure rate values than currently marketed FDA-approved products for treatment of bacterial vaginosis.1 DARE-BVFREE Study: • 70% at Day 21-30 (primary endpoint) and 76% at Day 7-14 2 • Demonstrated that DARE-BV1 is significantly effective in what we believe was a representative patient population, including a large proportion of patients who reported one or more episodes of bacterial vaginosis diagnosed in the 12 months before they were randomized into the study (75% of the ITT population).3 • We expect pre-NDA meeting with FDA early 2021 and NDA submission 1H 2021 • NDA may qualify for priority review and, if granted, receive a 2021 PDUFA date, permitting potential 2022 commercial launch in the U.S. 12 DARE-BV1 Qualified Infectious Disease Product (QIDP) and Fast Track Designations QIDP and Fast Track designations support request for Priority Review 1. Based on topline data from the Phase 3 DARE-BVFREE study and the prescribing information for currently marketed products. 2. For more detail regarding topline study results see our December 7, 2020 announcement available at: https://ir.darebioscience.com/news-releases/news-release-details/dare-bioscience-announces-positive-topline-results-dare-bvfree 3. Prior episodes were self reported

 
Sildenafil Cream, 3.6% Potential First-In-Category treatment for Female Sexual Arousal Disorder (FSAD), which has no FDA-approved therapies Novel cream formulation of sildenafil to treat FSAD, utilizing active ingredient in Viagra® 13

 
FSAD – The Clinical Issue Female Sexual Arousal Disorder (FSAD) is characterized primarily by inability to attain or maintain sufficient genital arousal during sexual activity and, of female sexual function disorders, is most analogous to erectile dysfunction (ED) in men.* The condition should be distinguished from a general loss of interest in sexual activity and from other sexual dysfunctions, such as orgasmic disorder (anorgasmia) and hypoactive sexual desire disorder (HSDD), which is characterized as lack or absence of sexual fantasies and desire for sexual activity for some period of time.1,2 14 *Diagnostic and Statistical Manual 4th Edition Text Revision (DSM IV TR), defines female sexual arousal disorder as a persistent or recurrent inability to attain or to maintain until completion of the sexual activity, an adequate lubrication-swelling response of sexual excitement. The diagnostic criteria also state that the inability causes marked distress or interpersonal difficulty, is not better accounted for by another Axis I disorder (except another sexual dysfunction) and is not due exclusively to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition. 1. https://drgeo.com/womens-sexual-health-overview/; 2. https://health.usnews.com/conditions/sexual-disorder-dysfunction FSAD HSDD

 
FSAD – What Is the Incidence? 15 Meta-analysis of 95 studies from 2000-2014 indicated prevalence of Female Sexual Dysfunction in premenopausal women worldwide is 41%, and difficulty with arousal alone is 23%.1 Market research estimates: • 33% of US women aged 21 to 60 (~ 20 million women), experience symptoms of low or no sexual arousal.2,3 • 10 million women are considered distressed and actively seeking treatment.2 1. McCool et al. Sex Med Rev 2016;4:197-212. 2. Ad Hoc Market Research: FSAD Prevalence Report (Oct 2015) conducted for SST LLC. 3. Based on US Census projections for 2016.

 
1. Sildenafil Cream, 3.6%, (formerly SST-6007) 2. https://qz.com/quartzy/1238783/its-the-20th-anniversary-of-viagra-heres-how-its-changed-the-world/#:~:text=Annual%20sales%20of%20Viagra%20peaked,Viagra%20is%20set%20to%20expire . Sildenafil Cream, 3.6% - Product Profile Topically administered investigational Sildenafil Cream1 is… • A PDE5 inhibitor utilized in ED medications for men – ED product Viagra® peaked at $2.05 billion in sales in 2012.2 • Designed to increase local blood flow to provide improvement in genital arousal response. • Applied topically, avoiding hepatic first-pass metabolism response, resulting in lower systemic exposure potentially resulting in reduced side effects vs. oral sildenafil, including Viagra® • Given similarities between ED and FSAD, sildenafil - the active ingredient in Viagra® - may improve genital arousal response and overall sexual experience for women as it does in men. There are no FDA-approved treatments for FSAD 16

 
17 Sildenafil Cream, 3.6% - Phase 2b The planned Phase 2b clinical study aims to evaluate Sildenafil Cream vs. placebo over 12 weeks of dosing following both a non-drug and placebo run-in period. • Compares Sildenafil Cream vs. placebo in patients’ home setting. • Primary endpoint: patient reported outcome (PRO) instruments to measure improvement in localized genital sensations of arousal and reduction in FSAD related distress. • Several exploratory efficacy endpoints will be measured and could become additional measurements of efficacy in a future Phase 3 program.

 
Ovaprene® Investigational potential first-in-category, hormone- free, monthly birth control Partnered with 18

 
19 • Bayer received the right to obtain exclusive US rights to commercialize the product, following completion of the pivotal clinical trial if Bayer, in its sole discretion, pays Daré $20 million. • Daré may receive up to $310 million in commercial milestone payments, plus double- digit, tiered royalties on net sales. • Bayer supports the development and regulatory process by providing up to two full-time equivalents (internal experts) in an advisory capacity, which gives Daré access to their global manufacturing, regulatory, medical and commercial expertise. We believe the licensing agreement with Bayer is validation of our broader corporate strategy and confirmation of Ovaprene’s market potential, if approved, as the first monthly non-hormonal contraceptive product in the US market. * https://www.mirena-us.com/; supported by 2014-2016 SHS data. 1. https://ir.darebioscience.com/news-releases/news-release-details/bayer-and-dare-bioscience-announce-exclusive-licensing-agreement January 2020 - Bayer, which markets the $1 billion Mirena contraceptive franchise, and Daré announced the execution of a license agreement under which Bayer may commercialize Ovaprene investigational contraceptive in the US once approved by FDA. Ovaprene® - Commercial License Agreement with Bayer1 Mirena® is the #1 prescribed IUD in the U.S.*

 
Contraception: Large Market Opportunity 201. https://www.bayer.com/en/bayer-ag-annual-report-2019.pdfx. Includes sales for Mirena®, Kyleena® and Jaydess® / Skyla® 2. https://www.prnewswire.com/news-releases/allergan-reports-fourth-quarter-and-full-year-2019-financial-results-301001646.html 3. https://s21.q4cdn.com/488056881/files/doc_financials/2019/q4/2019-Form-10-K-Final.pdf. Lowest amount of daily estrogen (10 micrograms) available in pill form 2019 US sales: $588 million (Allergan) 2 Lo Loestrin® (norethindrone acetate and ethinyl estradiol, ethinyl estradiol tablets) Mirena® Hormone IUD (levonorgestrel-releasing intrauterine system) 52mg Physician inserted, long-acting. low/locally delivered hormone IUS 2019 worldwide sales: €1.2 billion (Bayer) 1 NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring) Monthly vaginal ring 2019 worldwide sales: $879 million (Merck) 3 Source: US Census Bureau, 2017 National Dataset (2016 is base population estimate for projection) https://www.census.gov/programs surveys/popproj.html Women in the Reproductive Health & Contraception Market Segment (over 60 million women) Successful Contraceptive Brands 63.6 63.9 64.2 64.6 65.0 65.4 65.8 66.2 66.5 66.7 66.8 67.0 67.2 67.3 67.5 67.6 67.8 68.0 68.1 68.1 62 63 64 65 66 67 68 69 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 F e m a le s a g e 1 5 -4 4 ( M M ) Year Total US Females Age 15-44 (Millions)

 
Ovaprene® - Potential Market Opportunity 1. Source: CDC National Survey for Family Growth,2013-2015 dataset, cdc.gov. 2. Market research study conducted in 2019 for Daré Bioscience 3. Contraceptive use data applied to 2019 population data from US Census There are approximately 65 million women in the US Aged 15-441 35 Million Women 2,3 Potential Candidates for Ovaprene 12 Million Current Hormonal Product Users 11 Million Current Hormone-free Product Users 12 Million Current Non-Users • Condom (6.6M) • Withdrawal (4.0M) • Spermicide/diaphragm (0.06M) • Rhythm/natural family planning (0.5M) • Pill (10.3M) • Injectable (1.5M) • Vaginal Ring (1.0M) • Patch (0.1M) • Emergency contraception (0.03M) • Currently use no contraception • Sexually active • Not seeking pregnancy 30 Million Women 2,3 Not candidates for Ovaprene • Sterilization (10.5M) • Pregnant/postpartum/ seeking pregnancy (5.6M) • Never had intercourse (8.2M) • Current LARC (IUD or implant) user (5.4M) 21

 
Contraception: What’s Missing from Current Hormone-Free Options? 22 Most Effective Pregnancies Expected (per 100 women) 1,* >27 18 12 <1 Spermicides & Vaginal Gels Condoms (male) Diaphragms (with a spermicide) Copper IUD 2 * Pregnancy rates tell you the number of pregnancies expected per 100 women during the first year of typical use. Typical use shows how effective the different methods are during actual use (including sometimes using a method in a way that is not correct or not consistent). For more information on the chance of getting pregnant while using a method or on the risks of a specific product, please check the product label or Trussell, J. (2011)."Contraceptive failure in the United States." Contraception 83(5):397-404. Hormone-free Options Easy-to-use monthly option Effectiveness approaching hormonal methods Least Effective 1. U.S. Food and Drug Administration Birth Control Guide dated 2/11/2020: https://www.fda.gov/consumers/free-publications-women/birth-control-chart 2. U.S. Food and Drug Administration Drug Data Prescribing information for a recently approved vaginal gel, Phexxi™ provides that in a multicenter, open-label, single-arm clinical trial in the U.S. (AMP002; NCT03243305), the 7-cycle cumulative pregnancy rate was 13.7% (95% CI: 10.0%, 17.5%), excluding cycles with back-up contraception, cycles <21 or > 35 days in length and cycles in which no intercourse was reported. The estimated Pearl Index, calculated based on data from the 7-cycle study, was 27.5 (95% CI: 22.4%, 33.5%). https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208352s000lbl.pdf

 
Ovaprene® Investigational Hormone-Free, Monthly Contraceptive 23 1. https://www.urban.org/urban-wire/women-want-effective-birth-control 2. Lessard, L,Perspectives on Sexual and Reproductive Health, Volume 44, Number 3,9-2012 3. Hooper, DJ, Clin Drug Investig. 2010;30(11):74963 4. Ersek, J, Matern Child Health J (2011) 15:497–506 5. In PCT studies of similar size, products (diaphragms) that demonstrated no motile sperm in the cervical mucus during PCT assessments later demonstrated “typical use” contraceptive effectiveness of 86-91% in pivotal contraceptive studies evaluating pregnancy rates over six-month periods. Mauck C, Vincent K. Biology of Reproduction, Volume 103, Issue 2, August 2020, Pages 437–444 6. Journal of Reproductive Medicine 2009; 54: 685-690 7. Trussell J. Contraceptive Efficacy. In Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar M. Contraceptive Technology: Twentieth Revised Edition. New York, NY: Ardent Media, 2011. Desired Features of Birth Control Products:1-4 Design Features of Ovaprene:5-7 + Efficacy 86% - 91% Expected Typical Use Effectiveness Approaching Hormone Contraception + Hormone Free No Hormones in the API Unique dual action MOA (spermiostatic & barrier) + Convenience Monthly Ring Form Women choose monthly rings for the convenience of a non-daily option + Favorable Side Effect Profile Safety Profile Similar to a Diaphragm No significant changes in vaginal flora and no serious adverse effects observed in studies to date + Easily Manage Fertility No Systemic/Long-term Activity Inserted and removed without a provider allowing for immediate return to fertility Spermiostatic Environment6 Contraceptive-loaded silicone ring releasing non-hormonal active Ferrous gluconate Physical Barrier 6 Three-dimensional, knitted polymer barrier

 
Early-Stage Portfolio Innovative prescription drug delivery programs DARE-HRT1 DARE-FRT1 DARE-VVA1 DARE-LARC1 DARE-RH1 ORB 204 & 214 24

 
Advancing Products Women Want 25 PARTNERS Product Candidate PRE-CLINICAL PHASE 1 PHASE 2 First-in-category hormone-free vaginal treatment for VVA in a hormone-receptor positive, breast cancer patient population. Proprietary formulation of tamoxifen for vaginal administration. DARE-HRT1^‡ Hormone Replacement Therapy - Phase 1 Started 2020 First-in-category combination hormone delivery platform for treatment of vasomotor and vaginal symptoms of menopause. Intravaginal ring (IVR) releasing both a bio-identical estradiol and bio-identical progesterone. DARE-FRT1^ Pregnancy Maintenance - Phase 1 Preparation DARE-VVA1^ Vulvar and Vaginal Atrophy (VVA) – Phase 1 Preparation DARE-RH1 Male or Female Contraceptive Target User-controlled levonorgestrel implant drug delivery technology is designed to store and precisely deliver hundreds of therapeutic doses over months or years in a single implant. DARE-LARC1^ Long-Acting, Reversible Contraceptive First-in-category progesterone delivery for pregnancy maintenance including the prevention of preterm birth and for luteal phase support as part of an IVF regimen. IVR releasing bio-identical progesterone. Timeline reflects management’s current estimates and constitutes a forward-looking statement subject to qualifications noted elsewhere in this presentation. Actual development timelines may be substantially longer, and Daré is under no obligation to update or review these estimates. “First-in-category” statements are forward-looking statements relating to market potential of Daré’s product candidates based on currently available, FDA-approved therapies. ^505(b)(2) regulatory pathway anticipated. ‡DARE-HRT1 Phase 1 study being conducted in Australia by Daré subsidiary. ORB 204/214^ 6 & 12-Month Injectable Contraception Novel 6 & 12-month injectable formulations of etonogestrel being developed as a longer-acting, reversible method of contraception with a more predictable return to fertility. A potential new rapidly reversible, non-hormonal contraceptive solution with application for women and men.

 
• Innovative women’s health pipeline with multiple clinical, regulatory and commercial milestones anticipated in 2021-2022. • Every program, if approved, represents a potential first-line or first-in-class product opportunity. • Experienced Board of Directors and Management Team with demonstrated success in clinical and product development, regulatory affairs, corporate strategy and financial operations. • Women’s health generating more interest as evidenced by transformational transactions:1-7 26 1. https://www.businesswire.com Dare Bioscience 2. https://www.businesswire.com KaNDy-Therapeutics-Ltd. 3. http://www.pharmatimes.com_acquisition_of_allergan 4. https://www.biopharmadive.com/news/astellas-ogeda-womens-health-deal 5. https://www.globenewswire.com The-Cooper-Companies-Announces-Definitive-Agreement-to-Acquire-PARAGARD-IUD-From Teva.. 6. https://www.statnews.com merck-to-spin-off-new-6-5-billion-firm-focused-on-womens-health-older-drugs/ 7. https://www.pfizer.com/news/press-release/press-release-detail/myovant-sciences-and-pfizer-announce-collaboration-develop Pharmaceutical companies will continue to seek new and differentiated products to supplement their branded women’s health offerings. Acquisition of Ogeda for €500 million upfront and the potential for up to another €300 million in milestone payments. AbbVie $63 billion acquisition of Allergan plc (creates women’s health franchise - Lo Loestrin, Liletta and Elagolix). Licensed Ovaprene from Daré Bioscience. Deal includes up to $310 million in potential commercial milestone payments, plus double-digit, tiered royalties on net sales. KaNDY acquisition for upfront consideration of $425 million. Spinoff Organon, a new firm focused on women’s health (including NuvaRing) and other drugs with projected revenues of $6-$6.5 billion (expected completion in 2021). Myovant to receive up to $4.2 B in collaboration to develop and commercialize relugolix in oncology and women’s health including up to $200m in regulatory milestones for the women’s health product candidate. Daré – Advancing Products Women Want Acquired global rights to PARAGARD® Intrauterine Device (IUD) from Teva in a $1.1 billion cash transaction.

 
NASDAQ: DARE www.darebioscience.com DARING TO BE DIFFERENT® AND ADVANCING PRODUCTS WOMEN WANT Appendix 27

 
DARE-BV1 Clindamycin 2% gel for Bacterial Vaginosis

 
N=307 subjects enrolled (age 15 and above) Duration ~30 days per subject Diagnosis - Bacterial vaginosis Definitions: Primary Endpoint: Clinical Cure (Day 21-30 visit): Resolution of the abnormal vaginal discharge associated with BV; Negative 10% KOH “whiff test”; Clue cells < 20% of the total epithelial cells in the saline wet mount. Secondary endpoints: Proportion of subjects with Clinical Cure, Bacteriological Cure and Therapeutic Cure at Day 7-14 Visit Bacteriological Cure: a Nugent score < 4. Therapeutic Cure: both a Clinical Cure and Bacteriological Cure. DARE-BV1- Phase 3 Study Design & Demographics1 29 • DARE-BVFREE randomized 307 women at 32 centers across the US in a 2:1 ratio to receive a single vaginal dose of DARE-BV1 (N=204) or a single vaginal dose of placebo gel (N=103). • The intent to treat (ITT)2 population comprised primarily patients aged 15 to 51 years, with a mean age of 34.8 (б=8.8) and median age of 35. Over 53% of the ITT population qualified as obese (BMI ≥30.0), with a mean BMI of 31.50 (б=8.5). • In the ITT population, 56.0% of women identified as Black or African American, 41% identified as white and 25.5% identified as of Hispanic or Latino origin (compared to 74.5% as not of Hispanic or Latino origin). • In addition, more than 75% of women in the ITT population reported one or more episodes of bacterial vaginosis diagnosed in the 12 months before they were randomized into the study (76.9% in the DARE-BV1 group and 73.8% in the placebo group). DARE-BV1 is a thermosetting vaginal gel formulated with clindamycin phosphate 2%, a well-known and well-characterized antibiotic designed for prolonged, localized release. 1. Data on file. 2. ITT population N=307 3. Visit occurred 7 to 14 days after study drug administration. 4. Visit occurred 21 to 30 days after study drug administration. The DARE-BVFREE study’s two treatment arms were well balanced in terms of age, race, ethnicity, bacterial vaginosis history, and body mass index (BMI). 3 4

 
• The study’s primary endpoint was clinical cure of bacterial vaginosis determined at Day 21- 30 visit in the modified intent-to-treat (mITT) study population (N=180). 1 • The study met its primary endpoint, demonstrating single administration of DARE-BV1 proved statistically superior to placebo (p-value < 0.001) at Day 21-30 visit. • DARE-BV1 also demonstrated statistically significant efficacy in all five pre-specified secondary efficacy assessments. • Summary of clinical cure results (mITT population), p-value < 0.001: • DARE-BV1 was well tolerated in the study. 30 DARE-BVFREE Phase 3 Study DARE-BV1 (N = 121) Placebo (N = 59) Clinical Cure at Day 7-14 visit 76.0% 23.7% Clinical Cure at Day 21-30 visit (primary endpoint) 70.2% 35.6% 1. In accordance with U.S. Food and Drug Administration (FDA) guidance, the mITT population (N=180) excludes subjects from the intent-to-treat (ITT) population (N=307) who subsequently demonstrated a positive test result for other concomitant vaginal or cervical infections at baseline. DARE-BV1- Phase 3 Study Topline Results

 
Investigational Hormone-Free, Monthly Contraceptive The U.S. contraceptive market size is projected to reach USD 9.6 billion by 2027 expanding at a CAGR of ~4.2% ~37 million U.S. women of reproductive age are estimated to currently use a contraceptive method 1. Grand View Research report, Feb 2020, https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market 2. The Guttmacher Institute, Contraceptive Use in the United States, Fact Sheet, April 2020, https://www.guttmacher.org/fact-sheet/contraceptive-use-united-states# 1 2 Ovaprene®

 
1. Anticipated regulatory pathway and timelines. 2. In PCT studies of similar size, products (diaphragms) that demonstrated no motile sperm in the cervical mucus during PCT assessments later demonstrated “typical use” contraceptive effectiveness of 86-91% in pivotal contraceptive studies evaluating pregnancy rates over six-month periods. Mauck C, Vincent K. Biology of Reproduction, Volume 103, Issue 2, August 2020, Pages 437–444 • Postcoital Test (PCT) Study - Completed 4Q 2019 32 Premarket approval (PMA) strategy The Center for Devices and Radiological Health (CDRH) as lead review division Step 2 (Ongoing) • File investigational device exemption (IDE) to support 2022 pivotal study readout. • Conduct pivotal study • Topline data expected by year-end 2022 • ~250 completers up to 12 months of use • Primary endpoints: safety and efficacy (pregnancy probability) • Secondary endpoints: acceptability, product fit/ease of use and assessments of vaginal health • Specifically, in 100% of women and cycles, an average of less than five (< 5) progressively motile sperm (PMS) per high-powered field (HPF) were present in the midcycle cervical mucus collected two to three hours after intercourse with Ovaprene in place. • Women enrolled in the study who completed at least one Ovaprene PCT (N=26) had a mean of 27.21 PMS/HPF in their baseline cycle (without any contraceptive device), a mean of 0.22 PMS/HPF in their diaphragm cycle (in the presence of an FDA-cleared diaphragm with spermicide), and a mean of 0.48 PMS/HPF in their Ovaprene PCT cycles (in the presence of the Ovaprene device), with a median of zero PMS. Mean Progressively Mot ile Sperm Median Progressively Mot ile Sperm Standard Deviation Interquartile Range Baseline PCT’s 27.21 23.20 17.88 24.80 Ovaprene PCT’s 0.48 0.00 1.18 0.10 Step 1 (Completed) The PCT Clinical Study Met its Primary Endpoint 2 Ovaprene prevented the requisite number of sperm from reaching the cervix across all women and all cycles evaluated. Ovaprene® - U.S Regulatory Strategy 1

 
1. https://www.businesswire.com/news/home/20190628005277/en/Global-Female-Sexual-Dysfunction-Treatment-Market-2019-2023 Female Sexual Arousal Disorder (FSAD) The global female sexual dysfunction treatment market is expected to grow at ~37% CAGR from 2019 - 2023 1 Sildenafil Cream, 3.6%

 
0 1 2 3 4 5 6 7 Mean (Erotic) Maximum (Erotic) V a g in a l P u ls e A m p li tu d e ( m V ) Mean and Maximum VPA† Placebo Oral Viagra® † Twelve healthy premenopausal women were studied. P<0.05 P=0.093 0 10 20 30 40 50 60 70 Question 2 Question 4 O b s e rv e d N u m b e r Im p ro v e d (% ) Improvement on FIEI Questions† Placebo Oral Viagra® P=0.015 P=0.017 † Question #2 – “After taking study medication, the sensation/feeling in my genital (vaginal, labia, clitoris) area during intercourse or stimulation (foreplay) seemed to be: (a) more than before, (b) less than before, or (c) unchanged”. Question #4 – “After taking the study medication, intercourse and/or foreplay was: (a) pleasant and satisfying; better than before taking the study medication, (b) unpleasant; worse than before taking study medication, (c) unchanged; no difference, or (d) pleasant; but still not like it used to be or I would like it to be.” 202 postmenopausal women with FSAD who had protocol specified estradiol and free testosterone concentrations, and/or were receiving estrogen and/or androgen replacement therapy were studied. Pfizer VPA Clinical Lab Study – Oral Viagra Pfizer Clinical Field Study – Oral Viagra Female Intervention Efficacy Index (FIEI) 1. The Enhancement of Vaginal Vasocongestion by Sildenafil in Healthy Premenopausal Women. Journal of Women’s Health & Gender-Based Medicine. Vol. 11, No. 4. 2002 2. Safety and Efficacy of Sildenafil Citrate for the Treatment of FSAD: A Double-Blind, Placebo Controlled Study. The Journal of Urology. Vol 170, 2333-2338, December 2003. Key Takeaways of Viagra® studies: • Increased blood flow and clinical efficacy observed with oral sildenafil (Viagra®) in women. • The side effect profile of the oral formulation was not optimal for women - leading to the exploration of alternative delivery options including a topical route of administration. Oral Sildenafil provided a compelling proof of concept for FSAD 34 Statistically significant increases in Vaginal Pulse Amplitude (VPA)1 Statistically significant improvement in genital stimulation (FIEI)2

 
Phase 1 Study of SST-6007 (Sildenafil Cream, 3.6%)1 Normal healthy postmenopausal women were dosed with escalating doses of Sildenafil Cream, 3.6%, using a cross-over study design. • Sildenafil Cream had significantly lower systemic exposure compared to a 50 mg oral sildenafil dose • AUC – 3-6% • Cmax – 1-2% • Sildenafil Cream was safe and well tolerated at clinically relevant doses (1-2g) • Favorable product characteristics as self-reported by subjects • Easy to use • Readily absorbed Phase 2a Study of SST-6007(Sildenafil Cream, 3.6%)1 Demonstrated increased blood flow in the genital tissue compared to placebo (mean change in VPA analysis) in 31 women (pre and postmenopausal) ~30 minutes post dosing. 1. Data on file. Sildenafil Cream, 3.6% was previously known as SST-6007. Sildenafil Cream, 3.6% - Phase 1/2a Study Results 35 Phase 1 Study Phase 1 Study

 
Positive Data- (See Figure 1) • Positive cognitive arousal responses were noted. • Significantly greater increases in genital temperature after application of Sildenafil Cream compared to placebo cream and no cream. • Significantly greater self-reported arousal responses reported during Sildenafil Cream visits compared to placebo cream visits. 36 1. Data on file. Statistically significant greater linear slope during minutes 11-15 of the sexually explicit stimuli as compared to the placebo cream for the vestibule. * Thermography utilizes sensitive cameras capable of detecting and recording temperature variations over time. Genital temperature changes are a surrogate for genital blood flow. Sildenafil Cream Placebo Cream Thermography Study Design & Methodology (N=6)1 Phase 1, single-dose, double-blind, placebo-controlled, 2-way crossover study evaluating the feasibility of using thermography to assess the pharmacodynamics of Sildenafil Cream, 3.6% in normal healthy women. The study required 3 visits and a follow up contact: Visit 1 (screening), Visits 2-3 (double-blind dosing) and a phone call (safety follow-up). Sildenafil Cream, 3.6% - Thermography Study Review

 
New investigational prescription drug delivery options for women Vaginal Drug Delivery

 
Intravaginal Ring Technology (IVR) Highlights The Vaginal Route of Drug Administration 1 • Vaginal drug delivery offers many potential advantages due to large surface area, dense network of blood vessels and high elasticity due to presence of smooth muscle fibers. • Recognized advantages include comparable ease of administration and ability to bypass hepatic first-pass metabolism. Our Intravaginal Ring (IVR) Technology – Design Features: • Sustained drug delivery, • Variable dosing and duration, • Solid ethylene vinyl acetate (EVA) polymer matrix that can contain and release one or several active drugs, • No need for membrane or reservoir to contain active drug(s) or control the release. 38 1. Sonia, T.A. & Sharma, C.P., “Routes of administration of insulin – Vaginal route,” Oral Delivery of Insulin, 2014, https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/vaginal-drug-delivery

 
1. U.S. Census Bureau, Population Division. Table 2. 2015 to 2060 (NP2012-T2). Released Dec. 2012. 2. The 2017 hormone therapy position statement of The North American Menopause Society; Menopause: The Journal of The North American Menopause Society Vol. 24, No. 7, pp. 728-753, https://www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position- statement.pdf 3. Anticipated regulatory pathway. Daré has not had any communications with the FDA regarding the specific marketing approval requirements for DARE-HRT1 or DARE-FRT1 . DARE-HRT1 39 Hormone Replacement Therapy (HRT) HRT remains the most effective treatment for vasomotor symptoms (VMS) and genitourinary syndrome of menopause (GSM); and has been shown to prevent bone loss and fracture.2 • The 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS), supports HRT in peri-and post-menopausal women.2 NAMS observes: non-oral routes may offer advantages over oral routes of administration.2 Ongoing Phase 1 VMS/HRT STUDY A Phase 1, Open-Label, 3-arm Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 (80 µg and 160 µg Estradiol/ 4 mg and 8 mg Progesterone Intravaginal Rings) in Healthy Post-Menopausal Women. N=30 Combination bio-identical estradiol + bio-identical progesterone IVR for hormone replacement therapy following menopause 45M women in U.S. approaching or in menopause1 505(b)(2) candidate3

 
DARE-FRT1 40 Assisted Reproductive Technologies (ART)/IVF As women wait longer to have children, infertility risk increases • ~12-15% of couples cannot conceive after 1-year of unprotected sex. • ~20% of US women have their first child after age 35; ~1/3 of couples in which the woman is older than 35 years have fertility problems. 1. Anticipated regulatory pathway. Daré has not had any communications with the FDA regarding the specific marketing approval requirements for DARE-HRT1 or DARE-FRT1 2. 2019 March of Dimes Report Card, https://www.marchofdimes.org/mission/reportcard.aspx 3. CDC’s National Center for Health Statistics, National Vital Statistics Reports, Births: Final Data for 2018, Nov 27, 2019, https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_13-508.pdf 4. https://www.nichd.nih.gov/health/topics/infertility/conditioninfo/common accessed January 8, 2021 5. https://www.cdc.gov/reproductivehealth/infertility/index.htm accessed January 8, 2021 6. Harris Williams & Co. Fertility market overview. May 2015. 6 Bio-identical progesterone IVR for prevention of preterm birth and luteal phase support as part of an IVF treatment plan 4 5 505(b)(2) candidate 1 Prevention of Preterm Birth (PTB) After steadily declining from 2007 to 2014, the US premature birth rate rose for the fourth straight year in 2018 with ~10% of babies born preterm (<37 weeks).3 2 NIH Grant Funding for DARE-FRT1 PTB Program Potential for up to $2.3 million in NIH grant funding to support DARE-FRT1 development • Notice of award for initial $300,000 in grant funding announced Aug 2020. Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Award Number R44 HD101169.

 
DARE-VVA1 Potential to be the first therapeutic specifically approved for treatment of vulvar and vaginal atrophy (VVA) in patients with hormone-receptor positive (HR+) breast cancer. • Approximately 3.8 million US women have a history of breast cancer; HR+ is the most common type.2 • Localized estrogen therapy for VVA may be contraindicated for women diagnosed with, or at risk of recurrence of, ER-positive and PR-positive breast cancer. VVA prevalence in postmenopausal breast cancer survivors is estimated at 42 to 70%.3 411. Anticipated regulatory pathway. Daré has not had any communications with the FDA regarding the specific marketing approval requirements for DARE-VVA1. 2. American Cancer Society, Breast Cancer Facts & Figures 2019-2020, https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf 3. Clinical Breast Cancer, Dec 2017: https://www.sciencedirect.com/science/article/pii/S1526820917300952 Daré is developing this novel local application of tamoxifen to mitigate the symptoms of VVA for patients HR+ breast cancer, including women currently on anti-cancer therapy. 505(b)(2) candidate 1 Proprietary tamoxifen formulation for vaginal administration for vulvar and vaginal atrophy (VVA) A chronic condition characterized by pain during intercourse, vaginal dryness and irritation

 
This exploratory study1 in four postmenopausal women diagnosed with VVA demonstrated that a self- administered vaginal suppository containing tamoxifen (20mg) dosed daily for one week and twice weekly for three months was effective in reducing vaginal pH and vaginal dryness. In addition, systemic absorption of tamoxifen was not significant: • After 8 weeks of study treatment with vaginal tamoxifen, median plasma concentration of tamoxifen was 5.8 ng/ml, with a range of 1.0 to 10.0 ng/ml • In comparison, after 3 months of administration of 20mg, once-daily oral tamoxifen citrate (Nolvadex),3 the average steady state plasma concentration of tamoxifen is 122 ng/ml with a range of 71 to 183 ng/ml 421. Clin. Exp. Obstet. Gynecol. - ISSN: 0390-6663 XLVI, n. 2, 2019 2. https://www.medicalnewstoday.com/articles/322537.php 3. US Food and Drug Administration: “Drug Approval Package: Nolvadex (Tamoxifen Citrate) NDA# 21-109.2002”. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21109_Nolvadex.cfm Vaginal Tamoxifen Enrollment (Baseline) On Treatment (Month 3) Paired Difference (Baseline vs. Month 3) Median Vaginal pH Normal vaginal pH is usually less than 4.5.2 7.1 range 6.5 to 7.5 5.0 range 5.0 to 5.2 -2.0 median range -2.5 to -1.5 Lower pH value is a measure of symptom relief Vaginal Dryness Rated using a visual analogue scale (VAS) that ranged from: 0 = Not bothered by dryness 10 = Extremely bothered by dryness 8.0 range of 7.5 to 9.0 3.0 range 2.0 to 3.0 -5.5 median range -6.0 to -4.5 Decreased vaginal dryness is a measure of symptom relief DARE-VVA1 Proof of Concept

 
(UC-LARC) / Microchips Technology User-Controlled Long-Acting Reversible Contraception

 
DARE-LARC1: Design Features of the Technology User-Controlled Long-Acting Reversible Contraception • Drug Storage • Individual doses stored in micro-reservoir arrays • Reservoirs are hermetically sealed at room temperature • Thin membranes over each reservoir protect drug post-sealing • Drug Release • Drug doses initiated automatically on schedule or wirelessly on-demand by the patient • Reservoirs are opened via electrothermal ablation of membranes • Upon opening, interstitial fluid diffuses in and drug diffuses out 44 505(b)(2) candidate 1 1. Anticipated regulatory pathway. Daré has not had any communications with the FDA regarding the specific marketing approval requirements for DARE-LARC1

 
DARE-LARC1 Grant Funding 45 The Bill & Melinda Gates Foundation has strong interest in family planning ~215 million women in developing countries lack access to contraception Grant funding to date: $20.5m Grant to understand user needs and define the product concept Funding 2013 Favorable response from Sub-Saharan Africa – Sub-dermal implant use is growing – 87% of women surveyed said they would use the proposed implant – 74% of healthcare workers said they would use the proposed implant in their practice Grant to develop implant concept and technology Funding 2014 – 2021 Currently executing a 4th supplemental grant funding to demonstrate multiple drug releases in vivo, after successfully completing additional market research and concept development in the 3rd supplemental grant funding

 
Financial Summary

 
Microcap Company, Actively Traded 47 * Share price and volume figures are based on the 20 trading days through 1/5/21; market capitalization based on 20-day average closing price of $1.28 per share NASDAQ: DARETicker Symbol 1.7 million shares Average Daily Volume* $1.28/share 20-day Average Close* 41.6 million Shares Outstanding (as of 1/5/21) $53 millionMarket Cap* https://ir.darebioscience.com/

 
Q3-2020 Financial Highlights: • Cash provided from financing activities* through 9/30/20: $16.7 million (net) • Cash and equivalents (as of 9/30/20): $5.4 million Updates from October 1 to November 11, 2020: • Cash provided by sales of stock: $4.5 million (net) • Common shares o/s: ~ 38 million • Warrants o/s: ~1.9 million Funding sources: • Since inception, we have raised cash through sale of equity securities, M&A transactions, warrant and option exercises, non-dilutive grants, and license fees • We endeavor to be creative and opportunistic in seeking capital required to advance our candidates, and to be efficient in use of such capital * Financing activities during the period included sales of stock, warrant exercises and proceeds from a PPP loan. 48 Daré Financial Summary

 
Grant funding: • $1.9 million grant for Ovaprene R&D expenses from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a division of National Institutes of Health (NIH). • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health Award Number R44 HD095724-01. • $20.5 million grant funding from Bill & Melinda Gates Foundation (2013-2021)to support development of DARE-LARC1. • September 21, 2020 Daré announced receipt of the final ~ $0.9 million in funding under the current grant from Bill & Melinda Gates Foundation. • Potential for up to $2.3 million grant from NIH to be awarded in phases to support the DARE-FRT1 program. Notice of award for initial $300,000 in grant funding announced Aug 2020. • Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Award Number R44 HD101169. Cost optimization and value creation through partnerships and affiliates: • Health Decisions, a CRO specializing in women’s health; agreement will provide dedicated resources and new pricing structures, which with Health Decisions’ expertise and established relationships, should accelerate development of key programs in a capital-efficient manner. • Avomeen, an accredited, independent contract R&D and manufacturing organization specializing in chemical analysis and product development; our agreement provides a preferred discounted price structure and access to Avomeen’s scientific expertise, including advanced instrumentation and development techniques. • Australia’s R&D tax incentive currently allows refundable cash credit of up to 43.5% of investments made by eligible companies in eligible R&D activity. We intend to apply for the maximum amount allowable under our DARE-HRT1 program. 49 Non-Dilutive Funding Sources

 
NASDAQ: DARE www.darebioscience.com DARING TO BE DIFFERENT® AND ADVANCING PRODUCTS WOMEN WANT 50

 
 GRAPHIC 3 darecorporatepresentatio001.jpg GRAPHIC begin 644 darecorporatepresentatio001.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#M?A]_R'YO M^O9O_0EKTJO-?A]_R'YO^O9O_0EKTJO)R;_=5ZL]3./]Y?H@HHHKUCRPHHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHII=0V, MC/UH =12 @C(I: "BBB@ HHHH **** "BBB@#S7X??\ (?F_Z]F_]"6O2J\U M^'W_ "'YO^O9O_0EKTJO)R;_ '5>K/4SC_>7Z(****]8\L**** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X+7/^1SD_Z]C_ .@F MNZDD2-2SL%4=23@"N#U22.Y\8,\4J,C6QPX/'W3WKFKMK/4SC_ 'E^B"BBBO6/+"BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BL;Q9KI\,^%=1UI;<7!LXO,$1? M;OY QG!QU]*S;;4_&TLT/G^&])C@9EWNNJLQ52>2!Y0R<=LT =7157^T[ 07 M$_VZV\FV8I/)YJ[8F'4,<_*1Z&L*+QMIB:]J^GZA=65C%8O D4\]TJ"?S(P_ M&<=,]B: .GHK%U36Y-/G?RX;>6!;":[W?:0'8IC "8R5.3ENW'K3?#WBK3=? ML+%X[RS6_N+2*YDLDN%>2+>@;!'7C/7 H W**Y2\\<6>DBS&J&TA>[U.2QCV M7B,JHI;]XYXQ@*,CL6 -:WB378?#>A7&J30R3^652.&/[TLCL%11]68#- &K M17*6_BV]LM06Q\3:9#ILDMK+=P26]UY\;+& 9%)VJ0Z@@]"",X/%5+'QQJ,D M6EZCJ6A+9Z-JLL<5K.+O?*AD_P!498]H"AN.C'&1F@#MJ*KWU[;:;8S7MY,L M-M A>21NBJ.IK$\(^+$\6)JDL5E/:Q6=Y]FC$ZE7D78CARI&5SOX![8^E '1 MT444 %%%% !534;Z'3;*2ZG8A$';J3V JW7"^/;EY;FST],X;YR/4DX']:PQ M-7V5)S6YTX2A[>LH/;J4DCU?QG=LQD,%DC8_V5]L?Q&B:QCTOQ(MIDRI%:D$ MG@M\I-=[IUE%I]A#:Q* L:X^I[FN+US_ )'.3_KV/_H)KD6']FX2D[RUA5A!6@HRLOEU+\6A-3V--5J?E='3BBH; M67S[6*7^^H:IJYMCT4[JX4444#"BBB@ HHHH \U^'W_(?F_Z]F_]"6O2J\U^ M'W_(?F_Z]F_]"6O2J\G)O]U7JSU,X_WE^B"BBBO6/+"BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHS0 4444 %%%% !1110 44 M44 %%%&: "BBB@ HHHH **** "BC-% !1110 449HS0 4444 %%&:,T %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <=\5 M?^27>(?^O4_S%<]I>I>!(+ZTEB^(&I33)(A6&76Y71VR,*5)P0>F*]2(!&", MBF^6G]Q?RH \<\3_ &6X\:WFL06TTOA>QN8$\0"-OW<\Z9VOMQ\PBRA?UP.# MM-=%I6FZ9JGCOQU.G7BO0MHP1@8- '0 4 > M*:&[/I?AQG8L?^$+O!D^@,0%2Z9<>'[SPWX"L/#PMCK<%U:2210*!/ H&;AI M,&R,9XKV;:OH/3I2"-%C>.H+&Y\%ZA]O%W]F14E,EFNZ6(JZLLBC_ &2 Q]@: MZ$HK*5905/4$<4Z@#R2SA_X27QQI(4\36]A8W1NI+2%(X465 BQ_*2#(^ M23\W11P*RU6/6-/\-Z'IGBJ;4XX[^V>'3&MT2XLXHG!;[202?D52HR%R<=:] MMCCCB7;&BH,YPHQS0L<:NSJBAF^\P')^M %6TU*QU">[@MITEDLY?)N% /[M M\!L'\"#7-^"O^0WXS_[#1_\ 1$-=> !G ZTH '0=: "BBB@ HHHH *X'QRC6 M^M6-YCY-H'XJV?ZUWU9/B#1UUG37@R%E4[HF/8US8NDZM)QCN=>"K1HUE*6V MS^9IPR)-"DJ-N1P&4^H-<+KG_(Z2?]>Q_P#033-!\22Z(QTO5D=$C.%;&3'[ M'U%1ZE=P7OBQY[:598S;'#*?]DUA]8C6]G;?F5T;RPLZ"JW6G+*SZ,[/0?\ MD"VWT/\ ,UF^*YE$$$(^\S%L>PHL=9M;'18$9]\H!_=KUZGKZ56T^VGUG4?M MUR/W*G@=CCH!7LQBXRE5YI\/O\ D8)_^O5O M_0EKTNO*R;_=5ZL]3-_]Y?H@HHHKU3RPHHHH 0UX]K/QLN=+U[4--7189/LM MS) &-R06"L5SC;QTKV&OD7QFC_\ ";Z^0I&=1N"#_P!M&J),TIQ4GJ>F?\+X MO@I;_A'8>#_S]'_XFHV^/]V@.[P]"/;[4?\ XFO&DEE\U4 .<]J?)(48HZ]^ M2:CF:ZFOLXVV/9(_C[F+H_P#Q--?X_P!XO3P]$1ZFY/\ \37CH\M) M 5! -/DQ+D*1P:')@J<;'KW_ T#=?\ 0OP_^!1_^)I?^%_W973D^E-\O)(R2:7./V2['L0^/MV1G_A'X?_ */ M_P 333^T!=@X_P"$=A_\"C_\37CZC!Q3O(;:2!D4<]@]DNB/7_\ AH"Y_P"A M?A_\"C_\30/V@+DL!_PC\.#W^U'_ .)KQHQL#DJ0*124;CC%/F8O9I;H]L7X M\W#=-"AZ\?Z2?_B:D'QTN0H:30X%!Z?Z2?\ XFO'8F\L[\X4CG(Z57D?S&VE MC[&HYI7W+=.FEL>S3_'F>%@!HD#CU%R?_B:8OQ]G(_Y ,6?^O@__ !->,.=@ MPS;N/RJQ!:^B/7Y?CY=1JN- A8D]/M)X_P#':&^/=XJ@ M_P#"/0X/_3T?_B:\>E4P.05Y[9I&=RHW=*2DP=./8]EM_CQ=3AB= A4#_IY/ M/_CM2-\<[Q%8_P!@0G'I>5]R_902V M/7E^/=TW_, @ [G[2?\ XFB3X^7*' T&%OIRAV/7O^%_762!X?AX_P"GH_\ Q-2O\>+M<;?#\+<<_P"DG_XF MO%F 5\GCM4J98 %3CU%#E(2I0['L ^/MV2<>'H,#_IZ/_P 35BV^.5[=.$30 M(2Q[+=$D?^.UXTEN^",%23WJZL[AH MAH4#[>I^TD?^RTR+X\WD@S_PCT/X71_^)KQ%F>5R23D\FM/2QB0!AUXJI2DH MW)C"$I6L>QGXY7**&?08P#W%P3_[+44GQYE1,C0XBV> ;@__ !->92VY$FY6 M^3J0:H7-DA/FJQ*>PXK*-5O=FT\/%;(]8_X7S>XR?#T&/:Z/_P 337^/MT@S M_P (_!_X%'_XFO('D:-1&I! [U"VY@69>!WK7F9C[./8]@/[0EX#C_A'8/\ MP*/_ ,34Z?'RY*$MX?B#=@+DX_\ 0:\4)VL#MXK3L4-Q('$;,%Z #/XT2FTK MA"G%NUCVW1?C'=:K=-"^BQ1ML+*%G)9L?\!%7[?XJO,Q#Z8L7RD@M(<\6X&^,(V!U&[\:[J/3TU#PQYB7(#R;MYV\!CV]JQ=2?1FZH4UNCM]=^ M*L^EV,-W:Z9!=Q2#DBX(Q^E5=(^,4FKV[^7I<$=RO(C>QVUXWK+>2YM4 MD+*F-^UOES["J$$I0;@Q&/0XJ^>5MR/94T]CWJY^*]W8*#=Z)M&[!\N0M_2H M8?B[>7Q?^S]$24H/F#S%3_Z#7C0D]%7@4 MU*75DRIPZ(]>F^/3*J&'1$R M(\EV\<(49*LV#5M/""*@E\Y$.?X^,'\:/;6>XEA[ZV/IN"3S88Y",%E#8],B MI*AM1BVB&C-429^IZ+8ZLFVZ@#$?=<< M,/QK%M_!-M:71EANY<%67:R@]1CK74YI&8*"QZ 9-8RH4W-3:U74UCB*L:;I MJ7NOH8]MX:LH6#2%YB.S<#\JV5144*J@*. !VK.T[4+B_N)66U,5FO"22<,Y M]E["KAI^: %HI,TM !1110!YK\/O^0_-_U[-_Z$M>E5YK\/O^0_-_U[-_Z$M>E5 MY.3?[JO5GJ9Q_O+]$%%%%>L>6%%%% "&OE?QBT;^+]:0@;OM\XY/?S#7U0:^ M4_&$:MXPUK>"#_:$^#_VT:L:VR.G#;LSH+:&'+28)]/2J]Y'#O\ ,!X/6GB1 ME&P)YF.I)P:G62!V,7V?Y@.:Y;M.[.^T91LC'8Q;N&^G%*<>F#[5'+@1\\=,Y_9M;E2*!W=0$X//2M8Q%<'IG@8JHD$L1)#_@35DD[4 M;7R"'XZBHUN5A/S\@#I4B7))<(@ Q@$\FJ?V:>_!IK>R%)W]YDC[=K+NY[8JL69E ! VTZ/RB3YF]N.BD#]:?:6L$LV'N!$ MA/4\XJU9&;=]BLL;3S+$I&]CCD\5O0:/JL5W]GBMA+(%#$1,&P/PIS>'$RKJ MY9,960#"D^A)Z5#]EGLKKRDNH8F<9WB3&T>AZ4G)/0I0<=61W\!GUIV)YALV"Y.1Q^M26ZYB)[=*A8;F X[U;@E M6*"2/&X'!ZG*7;YO?KBD<;B, \]JMPINA Z<\"I;L6DVR MHX,C@$9YK4M;1A'N3/)Q]*A%L3\D0+2=\$?E6W#I%Y#9B22#9CC#=:B@-.7 8C< !E MS(O0>M2'PF)"KO=,0QQD#@4H-)>\744I?"<=ACD#KV%6HK:[GM741%CN!!_I M74&DC#@#YMM;&@VTEE'_M[JSB-K*^\[MP Y"UT5K>W6B>% M#*J9AE38X<]5Y_$%@$/E7,$DK8'F/"14+VY.TQJS>P%='IWAU1?1V\FI67V< MDY?SAD?@<'-=_/I[Z;I(ATG34N"F.)HPP<'J0>YK1.S,W%-:GE/A^Q>^U:(F MR-RJG)A4X) ]Z[/77T^WTZ.80HK%BOV!]@5>Q)[FNCN(1<6TL+?=D4J?H1BN< MT[6%T.W73M6#PM#\L14U"SO M-/U;28'NGN+,W2M&TO+HWH3W%:FH2W>IZNVE6L[6T,*![B5/O'/11Z?6H5F; MQ#JUI+!$ZV%H_F^:ZE?,?L%'I3[UI=&UN34O)>6SN8PDQC&3&R]#CTQ6"22; M5^5O\+?E%);^V MK>I/6L^YU>'4]2N([K4I;.RA?8L<((:0CJ2P'2NKL%*Z;; @@B)01^ KGX+D M>&[NY@O8G^Q2RF6*X5-P7=U5L=*)PY815].M_P!14Y\\Y.VO1+]"B-6M](NH M7L-2GN[9FVRP3!F*C^\I([>E=-J)E,EIY./,:0@%NWRGFJ*:X=1O(H=)@\Z/ M=^^N'0A%7T'3)K5NXW*1RQKN>)MP7U'0C\JWPMDW9W7X?JB& M_P!G1$9=YFD[OYK _H<4ML\J326TK;R@#*YZLI]??BD&IVFW+3*C=U;AA^'6 MBVWS7$ERRE%90B*1@X&3D_7-=6MM3C]VZY189';4;I"Q*JJ$#TSFF.'O+J2+ M>RPQ85]IP68C.,]A@BG0*1J=V2#@K'@XZ]:89/L5U,\@(@F(;?CA6QCGVX%/ MT$]M=KBR6/D*9+1W20C@'!JM)J$3J4M6$TI'"HPJQ:PBWMHXLYVJ!GUI.]M2HVYO=V)J***DT/-?A]_R'YO^O9O_ $):]*KS M7X??\A^;_KV;_P!"6O2J\G)O]U7JSU,X_P!Y?H@HHHKUCRPHHHH 0U\M>*/F M\9ZVC#(.H3]!G'[QJ^I37S!XK$<7C'6"KQJX\Q1D P6&[ MKS5>168%0/K6M+#'*0V5W \'TJ,0JSD,,D<9JU-&4J;,Z.T;)8$CCI4CVFX! M?,!..]::QA3@)S4?D[F88Q]*?M&Q>Q1G1Z> ,EV# \C%2L\L**B,,+T9>OXU M<,*8())'4U)%I\]U( A3#?* &RQ]@!1SWW#V:CL9GFNPR22/0UFWL1>3$&= OV@+-CE-AROU["G?\(E#"7!8SV[10^6BOC#Y9SDL.^!V^O%<];7RPW<(L MHL+QO:4XSZ_A3AS;BGRW+4EIOC+0VY+'"@8.2?8=Z@;1V.E_;@R[0V#D$$'T MKTO3;.RF\V_M4B*B,%I-Q';[H)Z'I6#J4UWK!D>73I))(1M2"( (1V8D=:$P M:1Y\\;N1C%->)XVP>:W_ .P]3E8-':@$#+J<*5_ ULV_@V>-0;R1 78#>IW# M![#OG\*KFL9\MSC[6W;)]6''.,4Z6-3L6 %E/WB1SFNVN_!:6;%9[Z %FVYV MD8]?QJ!?#?EW$8%U&UN#@R)C(YQ^)J>32)-*TAP0/*0[!CW/\ M2LY2;-8Q2,"+3W"%XI8B,@CYCGWSBNFM;"6X5KB:5A(O(56(0?A66]U'9PJ+ M*Q>0XP7V;58^GJ15BQU+45*27D:M(?N1(HPH[5$[V-*:M(T;O55AM]HUD#R#GC/\JYE+.*>Y*/<;6/ MW(V!&XY^[GH**,5;4>(EKH=7I^H:2.DS1A?*53C8/ZTMK:O<'>,[1U)Z#ZUO[/NSF]MT2U.JN/'3R M7 6TLDC5N"6 R?RJA>^+M2EE=4$:@# .,X/^?6LQ9["WNU $DZ@C<4X'OC-; MW_"+6VI6[7.C79D?&YK>0?,/RHY8]4"G-K1G-W%]?W?_ !\74T@]&8XJF05^ MM:%SI]W;%]T9&PX92?F7ZBJ;*0 [!E)]16BL9/S(Q(R]J<'![&E,9)!Z@]Z= MY>[IVHNA),C#?-Q6KIUO#>1+$TPCE1BV.^/05G>5M..AQ3D+0R(Z9# YR*4M M59%0]UZFO?V[6T<3H3)"ZY5_?O5S0_%>L:-,K6]T7@_B@D^9#^';\*OP7(N- M+%K+"GDW*[ED09*MWX_"N>GM)+,&.1,,IP>:YXRZ,[)0Z]#UG3O%6C^(8C&8 MTM+\)N_?+E./>I+FU%FR2F&-5?D/$.*\CT^5X[I7!QM.2<=J[6SU6Z^S%M/N MA(A'^I89*GZ'J*FZ%IF XW-'UQZXIQJ7)E2L>? M+#J-TR,S+"JC"[SC JTMG A\V9IYG4]4X!KK-0T^"6V2[L45]Z[E(3D#'I5: MQM$:T#/>2/=-SY;J%'X42F@5-M'OEMS;1'_8'\JFJ*W_ ./>/_=%2UZ"V/(> MX4444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !32BMU /UIU% ";105!I:* &B-5' ^E+@8I:* M+ (!B@J#UI:* &A%48 P/04[%%% #=BDYP,^M+BEHH"PF!00"*6B@!H15Z # MZ4ZBB@ HHHH \U^'W_(?F_Z]F_\ 0EKTJO-?A]_R'YO^O9O_ $):]*KRK/4SC_ 'E^B"BBBO6/+"BBB@!#7RSXQD">+-;"L/\ C_GR/^VC5]3U\C>, MR8_&FO'G!U*XR/\ MHU958W2-\/+E;'6CHB!F=>3WJS-$CH3P0>M8*P274:G M.T9SD5H">6) J[64=<]:XIT];IGITZONVDM!4LHURT9<-[FI8Y @V/\ GFHA M>>8??-0[I"V 1CVJ_I9M2S-) M97N8,4+-$TC.58#@,, M _C6GING7%W(RQ0 )CYF<@ 5HG5-*CD$<\\;MDX,,;;5S_.M"?7-'MI(HY7D MF 4$;$X^IYIZDW2T*L7A,"$3339_V1P/SJV\<%K,MM:Q(A52IK.U+ MQ1""5MXY'1AP9!\I_#/2L%M3BN)@UV2I/&Y!C:*5I#NNIT$EUY'SI)+$ >=@ MPH/K@]:R;G5+RXOT%M&K[!Q,PR1D]?05)'_9WF@RW?FA02H5N3Z YJ6U0R@I MYH1#D[<84'L,#K6D#*H^AG$W]K+ONY$*27,=Q&MS%&TDJG@ MEB^S\,X_G6C=Z?')*QNY0P;&U!U0>H!]:H7-Q96=K<+%&[N%V;XP J_C6G,M M$8\CLV5I-(LI(E;5-1D@F<[]KIEL9]JV-'L/"/V66.75(S,YQ&[(05]L5PH6 M:9F9B6)[G_&MCPSX=_M2EHC?GBM;68VB: MG]NC=P8X8E*Q@]LG.>YXK0M4N[>0R1O*9,8ZG:OJ *?:^&[*UNDN"\DLB=-Y M /K@5KUU0R^4]9NQYM;.Z=-VI1YO,H?V:I=I#)AW !(7G\Z=%8^4Z_O7*I] MT$YQ5S'-&*[88&C#H>35S?%5+J]ASR-,S-)ABWWB0.?K6;>:2EQ%M@E:V.<_ MNP,?E6CBE(K9T:;5FCECC,1%W4V<[)X7>8?O=1G;U!Z?SJXWARP:V\M$*/VE M!^;-=!IUA)J5]':QLJL^<%NG S6^/ U_C_CX@_6L72P]/1H[%BL=62DF[(\H MO/"$QD#P2AQW#&L^;3-3TN,OYAC53P2=P:O:?^$&OS_R\0?K4&:9Z<<;!I_D>=>)M'MM0U)[VU9(T< LJYQGZ=JB%C:Q:8]@;IXC, ?,* MX08]>]>QGX:R/%Y;M;.,8.[.?SJA<_!^.6+$MR:>*A-V MY6O4\9LY(],NRT<<,Y*[6W X/N*T+76A977G6X:V9L[FC4,2/QKKM?\ A=<: M+9).]U&S.^T;GQ'1%IJ\=3H+C5]#U9E^WSR;A MU=H\/^8ZB@>%(KZW>?3;V.XAQE49O\X-NV3Q3IFH,8-13[)(W#-M+( M3ZCKBJ&LZ/$$6:&,M$PR)$(8?F*.9K'._P 1,PXQ_=;^E9586]Y&U"K?W64KFV M;P]>^;+"S1YVD \'Z>M:9TZ*>V.H:5(S0,,E!PT?KT]*WM2N+:XM L\49<<2 M @L"/4 ?Y[U2T73UTVZ-W:DS6FQGZ=_:,4GG86 MYC7/5P"P],UTHNME@LPC66S!RZ-]]%/4>^*I7MO&)?)52L-RVX*F=T;?WAZ5 M;TEII)9K6Y3YD78V1UQT/XBLW+J:*.EAT36\T8:.9I+4/D-'P5]/PJU>:;;3 MLCV\P24G[V.&XZ$CH:C&EI9W3M;YMMYW';RK?4'C\JP?&4]_"5=6\N//S2Q9 MRWUQ6D;29G.\4SZ*MQB",'LH_E4M0VG-I"?6-?Y5-7KH^>>X4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >:_ M#[_D/S?]>S?^A+7I5>:_#[_D/S?]>S?^A+7I5>3DW^ZKU9ZF+Y2/'&OCK_Q,KC&?^NC5]=&ODWQQ'*?&>L[E"#[?<%3CJ/,/ M-9U&;45=LS(&5E!24AAU%6/*++D/NS6, RN<H'4UFV^IHHKH5Y&^8*2<9[ M4K0H3E&+?48JQ=VACQR&;L!26L4]P^R& M[@4U+30EPUU+6FVD;R O$)"#\H MW '/TKHK>QU"4Y.R6I,I4X+F;T16U+<[1QVL2QQ8VF0(-[?3N15NVTR)K8Q3Q[ MXSR0Z $_A6E%;)!DJ!N/4U)UKVL/E]K2J/7L?+X[.VTZ=!67?_(HC3[2. 1K M;0^6G(4H",T^"VB@3$421YY(10.:GF&(9#_LG^5+CBO3C"*>B/"E5J3A:4FR M/%&*DQ1BK.>Q'UI<5+L'I1MHN/E(:4#FGE>>E!% 6-CPI_R,=M_P+^1JKXHO MKB#7KQ8YI OF< ,1VJWX4'_%16W_ +^1K+\7#_BH+O_ *Z?TK!_Q?D=D;K# MKU,W^U[S_GO+_P!]FG1ZM>&1?W\G4=7-4,4Z,?O%^HJWL91W1Z;KSD>,]$7L M?\:P?&EY/;Z],(Y7487@,1VK=U__ )';0_\ />N;\=C_ (GTWT7^5<]+XEZ' M;B=(RMW7Y&#_ &M>?\]Y?^^S_C2G5;P_\MY?^^S_ (U1Q2UT'%>1WWB:9SX0 MT-R&3D^]A]ZX:^!E#WZ6W8];!YO&I[E?1]SR9X,#+ -Z#'6K=OJ]Q M8Q/#!+^X?[\+#2N/F'X5QW_ M )CUN7^4MVUWIMR MS$;6=X4C/M5FRO;O3[C?:/(C+UQP,TK);%7=M45'M)K:0K)&0 ?2G2NLD+$LRR MY&!CK7HUEJFB>);95U14M[W&QG1<<]FK%O-&CTR[W7'[^S]<,/#^H1,]SIUVLBID*C/EA3+C5->LQ$)RZE5 MP"1QC\*AT?,M5^YW,%^LDIL[F,-$PPC-ZBI9],@OM.FMFG60MRH7L@$TK+Q@A21GWK,M[ZZMI5D@F=&4Y!!JH4'N3/$+9'V';#;;Q+Z(!^E3 M5#:DFUA).244_I4U>DMCQ7N%%%%,04444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110!YK\/O\ D/S?]>S?^A+7I5>:_#[_ M )#\W_7LW_H2UZ57DY-_NJ]6>IG'^\OT04445ZQY84444 )7R1XWN9)O&^MJ MV<)?SH"/3S&KZWKY(\9!O^$UU[8G74;C)Z_\M&K.I8VHWNSGP''0G/K4;.R' MKS5C[)0[5')&.:SYHI7-U"@JXGDQ7'F.3(H., =:7+8T5334; T;W)DD#JG "CGBMRS8W-P3 M\J)MP(D^]]3Z561WNF%KI\(@#XW$+N:NNTC1K32H/DCW3O\ ?D;D_2MJ.%G6 M>AR8G,*>%C>3U,Z/0#/RTN(WZ;!T]O>MR*"&*W\E(41>X3C-3]!28S7KTLOH MP6NK/F\1G6)JM\KLBD-+L% M(>.?N"I(K2" DQ1*I_E5C%&VNM0@MD>9*M4 ME\4GJ-Q3<5)BC;5W,K%>X'^C2_[A_E3PO HNA_HLO^X?Y5(J_**$]1V]P8%I M0M2;:-M%Q?(Z4OW"]3G-M.C'[Q?J*= MMIT:_O4_WA5O8SBM3T;7^/&NA_Y[USOCH?\ $]E^B_RKH]>&?&FB?Y[USWC@ M?\3R7Z+_ "KGI?$O0[,0O=EZK\CD\48I^*,5T7.%([;Q*,^#M _W4_\ 0*YW M'2ND\2#_ (I#0?\ =3_T"N>]*FA\/WFN,^->B_(9@T@>=$I8#&\<''UJWBFXJ)4X25I(TIUZM.7-"5C*'AW3DMVC@4HS<%C_C M7,:AX>O;/9Y;; M1R& K2L-9U&TF$:R*\3'!B=>#7H#6=J5*F"/!ZC;57^Q=.683+:H''Y?E6#R MZ=]&CL_MNC;X6<+K F:4.+5T+C<=HR/TK&QN)SD&O69K=98]H ! P../RK(O MO#-K.P90%XP2JYY]:PJX6K2Z71U4,?0Q.SL^S//H;B[LYA);7$L94YRK$?G7 M:6OBJWU#3TL]80Q$#'GCE&^H[&JUQX.F,/F0.,$< ]_:N7FAFMMT3YV\Y%<_ M,I:':HRAJ=3J&@6US EQ;,GDO]U@X(/N/3Z&N3NK&2W=@A+!>N#S3].GN-.G MWVT\D+$?=!^5OJ*UY=1L-0*F2$VDX&&:-N:$K/0KF4EJ?5%I_QYP?\ M7-?Y5/4%K_QZP_[@_E4]=:V/,"BBBF 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110!YK\/O^0_-_P!>S?\ H2UZ57FO MP^_Y#\W_ %[-_P"A+7I5>3DW^ZKU9ZF!]OF)8C_IH:^H#7S'XL='\4:TC MB_GX(X^^:YZ^R.O"*\F9 U(;FB M64.I'R@CK4UL))!O(7?T;;QFJB"")M_D*2.^*U+9P8#, #Z(.WN?:N.:LM#T M8._Q,BN(EB >1RCXR% R34-M;W-Q*J0C.VEQ4F*,4#L1;:7;3\4NV@+%6Z7_ $67_=J4+P/I27:YM7'T M'ZBIMN*74IKW41XI<4_;2[:=R;$>*,5)BC;2"Q%B@BI-M)BG<=C2\-#_ (GU MO^/\C67XK&=?(Z4OW"]3GL M4Y!^\7_>%.VTZ,?O%^HJFR$M3T'71_Q66BG_ #UKG_&XSK4OT7^5='K8SXPT M;_/>L#QJ/^)S+]%_E6%+=>AUUU[LO7]#DL48J0K2;:W.*QVGB,9\(:%_NI_Z M!7/XX%=%XB'_ !26A_1/_0*P@O%30?NEXM>^O1$6VDVU-MI"*WNAHSV,%FLZ-H5-8G ME L6N%<'_7-?Y5/4-L-MM$N< MX0#]*FJR HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH \T^'W_ ",$_P#U[-_Z$M>EUYK\/O\ D/S?]>S?^A+7 MI5>5DW^ZKU9ZF;_[R_1!1117JGEA1110 AKY<\5N_P#PF.M #_F(3CZ_O#7U M&:\=U'0;,^)-0D\G+MA5A2;E-V1YS!HE[<[24 M$2-WDXX^E=AI'A*ULX ]P6FWD,%884CZ=?SKHTBCBV^7&H8#&_'S?G2[VEVU(%I=M%Q\I'MI0M2[:-M*X^4CQ1MJ3;2[:+A8C MVT;:DVT;:5QV*MTA-L_X?SJZB/;1MJ3;1MIW(L M1[:-M2;:-M%PL1;:3;4V*3;1<+%_PZ/^)W!^/\JR_%(_XG-S_OUL>'UQK4'X M_P JR_% _P")O]8/C,?\3>3Z+_*M_61_Q5NC_P">]8?C,?\ $VD^B_RK&GNO0ZJ^S]?T M.4Q28J4K2;:W..QV/B$?\4IH?T3_ - K$"\"MW7Q_P 4MH@]D_\ 0*QMO%30 M?NEXM>_\D1XI-M2%:3;6YRV(]M-VU-MI"M%PL0[:;MYJ]/HQ0]@['L,'^HC_ -T?RJ6H MX/\ CWC_ -T5)7C/<^JCL@HHHH&%%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 >:_#[_D/S?]>S?^A+7I5>:_#[_D/S M?]>S?^A+7I5>3DW^ZKU9ZFCGI7G>HC_B9W?_79_P"9KIPWQ,X,?\**6*7%/Q2XKK/+L,Q2XIP%.VT- MCL1XI=M/VTNVE<=AH%*%IP%.Q2&D,VT;:DQ1B@=AFVC;4FVC;0.Q'MI0M/VT MNVD%BM#T+ ?J*FV4KZFC7NKYD6VC;4NVC;3(L1;:-M2 M[:3;0%B/;2;:EVT;:!6+N@C_ (G$/X_RK+\3C_B;W'^_6QH8QJT/X_RK*\3C M_B:S_P"_6?\ R\^1T+^"O4P-M*J_.OU%.Q3D'[Q?K5,A;G=:Q_R-FD_3^M8G MC$9U23Z+_*MS6/\ D:M*_P ]ZQ?%X_XF;_0?RK&GNO0Z:_POU.7*TF*D(I"* MV.0Z[7A_Q2^B^P3_ - K)V\5LZZ/^*8T;Z)_Z!63C@4J/PEXE>_\D1E:3;4N MVDVUL:_#[_D/S?\ 7LW_ *$M>E5YK\/O^0_-_P!>S?\ H2UZ57DY-_NJ M]6>IG'^\OT04445ZQY84444 (>E>>Z@/^)E=?]=G_F:]"->?WX_XF5U_UV?^ M9KHP^[.''?"BKBC%/Q1BNH\VP@%+BEQ3@M QE.Q2[:=BD,:!2XIV*7% [#<4 MN*<%IVVD-(8%HQ4@6EVT7'8C"TNVI-M&VE<=BG>?+''[RH/U%6,57U%?W,/O M<1C_ ,>%7-M*^I;7N+YD>VC;4FVC;3N18CVTA6I=M(5HN%B/;1MJ3;1MIBL7 M-%'_ !-8?Q_E65XE'_$TF_WZV-'&-4B_'^597B0?\3.;_>K._O\ R.A+]TO4 MP=M"CYU^M/Q2J/F'UILS2U.VU8?\53I9]OZUC^+A_P 3%_H*VM5'_%4:9]/Z MUC^+!_Q,&^@K*GNO0Z*R]U^IS&*,4\K1BMCF.KUP9\-:-]$_] K,"\5JZW_R M+>C_ $3_ - K.QQ2I?"5B%[WR1'BDQ4A6DVUJLP M?ZB/_=%25'!_J8_]T5)7D,^ECL%%%% PHHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@#S7X??\A^;_KV;_T):]*KS7X? M?\A^;_KV;_T):]*KRK/4SC_>7Z(****]8\L**** $-<#?C_B977_79 M_P"==\:X2_'_ !,;G_KJ_P#.M\/NSBQOPHJXI<4X"G!:ZKGGV& 4X"GA:7;1 M<=AF*<%I^VE I7'88%IP6GA:7;2N588!2XI^VEVTKCL, I=M/VTNV@=AF*-M M2!:7;0.QGZ@HV6^?^?B/_P!"%7-M1W2;A",9_>J?UJQMJ4]2Y+W41%:-M2[: M-M.Y%B+;1MJ7;1BBX6(MM)MJ7%)MIBL6=(&-3B_'^59?B0?\3&7_ 'JU]*'_ M !,8_P ?Y5E^(Q_Q,9?]ZL[^^;6_=_,P<4JCYU^M.Q2H/G7ZT[DI:G9ZI_R, M^F_3^M9/BL?Z>WT'\JV-3_Y&73?I_6H==T6[O[DR0!"IQU;%9P:5KG14BVFE MW.*Q28K<;POJ@Z0*WTD%59-"U./[UE+_ ,!&[^5:J<>YSNG)=#:UD9\.:/\ M1?\ T&L_' K2UI&30M*1U*LNT$'L=M4<<4J3T%B%[Q$128J4BDQ6ISM$1%-( MJ7%-*TQ$9%)BI-M)B@5B+%-(YJ4BFD55R6B(BFXJ4BFXHN)HB*TPBIB*815$ MD)6F$5.5J,K3Z"L>J0_ZF/\ W14E1P_ZE/\ =%25Y+/HX[!1110,**** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \U^' MW_(?F_Z]F_\ 0EKTJO-?A]_R'YO^O9O_ $):]*KRK/4SC_ 'E^B"BB MBO6/+"BBB@ -0_P#H#5/M MI+*,5)BDQ3N189BD(J4*2< 9/H*LQ:;<2G)78/5J.9(:@WL4,4;>U M:XLK*#F>?00>>#]*R_$0_T^ M3_>KH2R_\) %SR%_I6!XA'^G2?[U"=Y7&XVA;S,/%"CYU^M/Q0H^8?6J(2U. MLUF-I==L45BA9,4]JR MCK9&T[*[?T7G]YIZE#K%ZD<=Q;*1&VX-&.M56B9.'4J?0BEB\47D>-Q# M#T(J['XHBE %S;H?I_\ 7JDY1TL1-0F[M_>9Q%(16RKZ-??=D\A_3.*;-HD@ M7?;R+*OUYJE474S=![K4QB*0BK$MO+"VV2-D/H141%:IW,7%]2/%-Q4N*:10 M218II%2D4TBF)D1%-Q4A%-(IDLB(II%2D4TBFB;$1%,(J8K32*8EN>F0_P"I M3_=%25'#_J4_W14E>6SZ&.P4444#"BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** /-?A]_R'YO\ KV;_ -"6O2J\U^'W M_(?F_P"O9O\ T):]*KRK/4SC_>7Z(****]8\L**** $-<=>#_3I_\ MKHW\Z[$UR-T/]-G_ .NC?SK:CNSDQ6R*^*7%.Q2XKH..PT"G8IP'-.Q2*2& M4[%. I<4KCL(!2XIP%. J2K#<4N*=BEQ0-(;BC%/ I<4#&8H J3%&*5PL4[C MBYL_^NQ_]%O5G%5[K_C[LA_TU8_^0VK4M[-YCD_*GJ:F]C5Q;2L5%0L<*"3Z M"KL6G<;YWV+Z5*T]O9J1"H9N[&L>[U0N>6+'T[4KMARQ6YJM=VMHN((P3_>- M9=UK+/QOX]%X%9$MQ)*>6.*BQ322!MLL2WTC_=XIVF2.^JVV6/\ K!53%6]+ M'_$TMO\ KH*'L**U-\#_ (JH_P"X/Y5D^(!_IC_[U:X_Y&AC_LC^596OC_3' M_P!ZE'WS,3%"CYQCUIY'%"CYQ]:HSL=;J(_XJ'3_I_6LSQ-_Q\G\*U-0' M_%06'T_K6;XE'^DG\*B&Z-:FS.=HQ3L4F*T,!A6FD5)BD-.XK$8R#P:MVNIW M=HUEMWVRH5/OWJ$BK=EXE251!J40=3 M_P M .GU%6[C2UEB$]BXEB/.,\U2J=)&CP_ZI/H*DJ.'_ %2?05)7 MF,]^.P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** /-?A]_P A^;_KV;_T):]*KS3X??\ (P3_ /7JW_H2UZ77 ME9-_NJ]6>IF_^\OT04445ZIY84444 (:Y2Z'^F3_ /71OYFNK-.6">[8!T8F-,]3M(_'C-17VI84J"%7LH[UE:S?EM1LN:?BDQ5F=AE&*=BC% #<5:TP?\32V_ MZZ"H8H9)GVQ(SMZ 5LZ=HES%' M^EM]:THY$D\1L48,-H&0?:L_7A_I3?6E'<Z.->VF3[T,@/NIJ(@@X(Q78?:M93[]M&X^E1O?JPQ>:4I]P ?YU2DR M'!=SDNM)BNG:'0KG^"2W8^Q'^(J&7PUYB>98W:2KZ,?ZBGS+J3[-]-3G2*3% M6[K3[JS/[^%E'][J/SJM5)HAJVY&12$GZG#5XEL[\!;CHDG3M52!6R: M>QRR3B[,B(IA%3$4PBJ(:(C3:>:::8NIZ)#_ *I/H*DJ.'_5)]!4E>:SW5L% M%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@#S7X??\ (?F_Z]F_]"6O2J\U^'W_ "'YO^O9O_0EKTJO)R;_ '5> MK/4SC_>7Z(****]8\L**** UR]R/]+F_P!\_P S74&N9N?^/N;_ 'S_ #-: MTMSGQ&R(,4N*=B@"MCEL %+BG 4H%(8@'%. I0*4"D.P 4N*7%+BD4)BG8H% M.Q0-(;BGHA=@JC)-( 2<59FN;32+-KF\GBAX^](P 'YU,I6-(0IK+E\::+>SF"VU2WDF;L'QG\Z,ECDG-2F7.,HZ25BI;J$P'^P#4DFHP6J>1I\0)Z%\?YS55;2:Y?S;F0L M3ZTM6/1%AM72)?)TZW ']XC'Z56>.\N_^/B=L'^$<"KL=ND0PJ@4[%-)$N3& MZ9:I!=*5ZU1UT?Z4WUK6M/\ CY6LO71_I)^M/J+[)C8H4?,/J*7%*H^9?J*" M3J+W_D.V7T_K4>K:A-:3$(Y ]!4E[_R';+Z?UJCXA_UM2MT:3=KD*^(;A3R< M_459C\29XEC5A7.D4F*OE1'-)=3K+_[.UK!,J*OFX(X]1FL[R55M\99&]5.* MGU'_ ) ^F_1?_0:;C(HCL34T>A+'J%S&NR4+-&>"&'-1RZ7IFHY\@FVG/\)Z M'\/\*:132!3Y.Q*J-;F1?:3=V',L>4[.O(JA78P7[QCRYQYL1XYY(JI?:##= M1FXTX@'O%V_#THYFM)#Y5+6)S!IIJ62-HW9'4JRG!!&,4PU1F1D4G?CK3R*: M:8CI](U>._B&GZ@?F/$5;U%9HI!AE_6H#6Z=SEDFB$ MBFD5*13"*9"W._B_U:?[M25'%_JT^@J2O./K/4SC_>7Z(****]8\L**** U MS5P/]*F_WS_,UTIKG+@?Z5+_ +Y_F:TI;G/7V1$!2XI<4X"M3GL- I^*,4[% M [" 4[%&*6D.P"E S2@4H%!88I<4M2P1&60#MU-2W8:5]BO>7UIHVEW&JW[[ M((%W$^OT]\\5\U^+O%E[XGUF:]N'*Q$XAA!XC7L/KZUZO\:TOYM$MC;%C80N M?/13W_A)]J\&\MY/F/"^_>N:HY2=D>W@Y4<-3]K-ZLT]+TV6]5Y, @#"[C7I M_@C5;@E]+O)2QC4& N1[5R4 MZDXUN5G7B%3Q&'=2.IZ&XS?0>R.?U6K(!)Q4+*?MT7_7-_YI70V=G%80"[NP M-QY1#7HW/ :T0RSTZ*VA^U7V .JH?ZTRXNKC4G\N,%(!V]?K2MYVIW&]\K&# M\J^E:$<*QKA1BDA/LBM!9I"HX!/K4^VI,48JKDV(L4W%2D4F*=R6AUJ/])6L MK71_I!^M:]L/WZUE:X/WY^M+J5]DQ:%^\OUI2*%'S+]:HFQU%Y_R'++Z'^=4 M/$'^L_*K]Y_R&[/Z?UJCX@^_^53'<<]F8!&:3&*=0:LS-_4?^01IOT7_ -!I M,<"G:A_R"=-^B_\ H-&.!2AL%3<80::14A%-(JS(93H9I+=]T;8/<=C2$4E/ M3J&VJ+=U9VVMPD\1W:C@^O\ B*Y.ZM9;.=H9EVNOZ^]="K,C!D.UAT(J[-#! MK5KY4@"7*CY7Q_GBH^'T-+J?J<41FFD59NK:6TN&AF7:Z_K4)Z5=S)JQ$12Q MR/%*LD;%74Y4CL:4TTBGN3K<[&.5->TP2K@7<(PZ^O\ ^NLAEP2#U%4-,U"3 M3;U9UR5Z.H[BNCU2W1E2^@P890"<=C2B^5V'47/'FZF013"*E(II%;',=W%_ MJT^E/ID7^K3Z4^O/9[2V"BBB@84444 %%%8/B/7Y=$-L(X$E\[=G<2,8Q_C6 M=6I&E%SELC2E2E5FH0W9O45PG_">W7_/E#_WT:6 M5@D: LS'L*-@2OH)-<06X!FFCB!Z;V"Y_.B&XAN%+0S1R <$HP./RKS]UN_& M.N$INCM(^ QZ(O\ \4?\]*[RRLH-/M$MK9-L:#\2?4^]_,;BPU.XM5M(G6)MH8LW.>;& M(CVWD=T2K#,5T MU=%*M3JJ\',C@#N0.V.OX5S5L3&C*,9+IG'^\OT04445ZQY84444 !KGI_^/F7_?/\ MS70FL"B^+=3:[\;_ &5P3'#'L4'U(R37":K: M_9M4E55VQGYEV]*Q5>U?V3[7,:U)SH^U3T3L6-*3[1J,,)./-^0?[QZ?K7KN MD^$X-";[:7EN9D7*J, UXM;EED5E)#*001U!%?1N@6P\1Z-:O,6$!Q,XQ=&^@F@O(QDUW56CM[!%*0(QSDD@%L^G Q6YN?5+ MGS#D1#[H[8KSSXE:C*^HV6DPIY6FPKE O 9AQ^G2O1?#LL=QH-G*A!)B4-_O M 8-8QE>3B>E5I-053HS02-44*HX%.Q3\4F*T.:PS%(14F*3%,+$>*:14I%-- M.Y+0MO\ Z]:R=<'[\_6M> 8F6LK7!^]_&E?470Q2.*%'S#ZTXBD .]?K5DG2 MWG_(:L_I_6J>OCY_RJ[>?\AFS^G]:I:_]_\ *ICN.6Q@4E.I*LS.@U#_ )!. MG?1?_0:.PHO_ /D$Z=]%_P#0:7L*(!4W&FDIYIM69#:;BGFD-,1'BE5FC8.A MPP[B@TAH%Z%N^LTUJRWH +J,QKJ;>=K>8.OXCU%0^(= M/62,:C;@88?O!_6H^%V-7:<;]3F:::>:3%69-$?>ND\-W@N(I-+N#E6!,>?U M']:YPBGPS/;S)+&=KHP(-#C=!%\KN;<\303O$PY0XJ(BM;4MEY96^HQ 890' MQV_R:RR*N$KHSJ0Y9';1?ZM?I3Z9'_JU^@I]<1ZBV"BBB@84444 %<5X_P#O M:?\ 23_V6NUKBO'_ -[3_I)_[+7%F'^[2^7YH[LM_P!YC\_R9U-A#$=.M'C'X=*Y!TU'PAJJL&W1-T(^Y*OH?0_RKTJLOQ!IRZEH\\17,B* M7C/HP_QZ?C7'B<)%KGIJTEV.S"XR49>SJN\7W+EC>1:A9174!S'(,CU'J#5B MN,\!WC%;JR8\#$J#T['^E=D2 "2< =2:Z,-6]M24SGQ5'V-5P%J*6Y@A.)9H MXS_ML!7%ZOXEO-3O/[/T;>%)V[T^\_T/846_@6YF7S+R]6-VY(52Y_$Y%8/& M2G)QH0YK==D="P4814J\^6_3=G;1RQRKNCD5U]5.:?7#3>#]2TX_:--O=\B\ MX&8V/TYP:K7_ (CFO="FLKP&*^B=>0-NX \\=C2>-=-/VL+/IV?S&L"JC3HS MYEU[KY'H5%8GA)BWANV+$DY?D_[QKG?&DS1:_;D.P40*2 ?]IJTJ8KDHJM;> MWXF5+".I7=&^U_P.\9E12S,%4=23@"FQ313 F*5) .I1@:X@6^I>,;AYVE^S M:>C8C!&?T[GWK=T'PVFB2S2F?SI'&U6V[<+],^O\J*>(J5)+EA[O?_@!5P]. ME!\T_?[6_4W:@O(;:XMFCNPK0G[P8X!K)\1^(5T:$11 /=R#*J>BCU-R]A^5*MB;2]E"/,_P^8Z&%;C[6I+E73O\CM+$:=;1 M_9[)K=5SG9&XY-7:XF7P"P3,.H OZ/%@'\0:JP:EK'A>\2WOP\ML>@+;@1ZJ M?Z5FL5.E95:?*NZU1H\)"M=T:G,^ST9Z!145MECV[T[?RHX_Q?H5I#8_VA:Q+"Z,!(J#"L#QG' MKFM;PE>O>Z#&9"6>%C%D]P,8_0BL3Q=KUO=0+IUFXERP,CIR..@'KS70>&M. M?3=$BBE&V5R9'7T)[?D!44>5XR3I;6U[7*K^IR0HN5"52^UM#L**0D $D@ =2:X;5_$MYJ=Y]@T?>$)VAX_O2?0] MA3KXB%%7EN]D+#X:=>5H[+=]CM9;F"$XEFCC/^TP%.CECF7=%(CCU5@:XBW\ M"W4R^9=WJ1R-R0JES^)R*CNO"&IZ;_I&GW7FLG/[O*/^'//YUS_6<0ES.EIZ MZG3]5PS?*JNOIH=]17)^&_%#W5]D<\3O_ '5<$UQ6M75[KVO-H]H^R",E6YP"1]XM].F*?-X# MECBWVU^&F7D!DV@GZY.*YGBJDI/V4+I=;_D=*PE.,5[:?*WTM?[SMZ*P/##: MP(9HM30[(SM1I#\Y/?ZCWK==UCC9W8*BC+,>@%=5*ISP4[6]3DJT_9S<+W]! MU1RW$,/^MFCC_P!Y@*XG4/$6HZU>FQT972,\;EX9AZD_PBGP^!)Y1ON[\+(> M2$0M^I(KE>+E-M4(65\&D7D!E*'\"":-+\2WVF7PL-:#E0=N]_O)[D]Q0L9*$E&O#EOUW0/!1G M%RH3YK=-F=Q4,=I;13--';Q)*WWG5 &/U-3 @C(Y%<'X=D=O&5RI=B,R\$^] M;5JRA.$6KW9C0HNI"445R'B+Q-,ER=-TO)FSM>11DY_NK[U5:O"C M'FD10H3KRY8'5R3Q0C,LJ(/]I@*(KB&;_531R?[C UQ%MX*O[P>?J%YY1>0&4H?P.37-]9Q%N;V6GKJ=7U;#7Y?:Z^FAW- M%<3HWB6[L;W^SM9W#!VB23[R'W/<>]=M730KQK1O'YKLE-FUC4=:DCTW1MR1H@$LV<9XYY[#]36$\;&-25-K56MY MW-X8&4Z<:B>CO?RL=E)=6\+;99XD;T9P*D5E=0RL&4]"#D5QJ> MR9FU$F0\ MG;'D9_$\UG7%KJOA"Z2:*;S+=VQD9VM[,.QJ98JM3]ZI3M'UN5'"4:GNTJEY M>EKGHE%5M/O8]1L(;N+[LBYQZ'N/SJPS*BEF(55&23T KN4DU=;' XN+Y7N+ M48"N*U+Q)?ZO>_8-%5U0G&].&?WS_ BG0>!;B8>9>7X6 M1N2%4N?S)%<3Q@<$UP=MH>L^(R+N\N"D3 M:YH4]/-V.UX7#P?+4JZ^2N=K M17GT5[K7A2Z2*[#2VI/"EMRD?[)['V_2NZL[N&^M([FW;='(,@_T-;4,3&JW M&UI+=,Y\1A944I)WB]FB>BBBNDY@HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@#S7X??\A^;_KV;_T):]*KS7X??\A^;_KV;_T):]*K MRK/4SC_>7Z(****]8\L**** $K"G'^D2_[Y_G6[6),/](E_P!\_P Z MTI[F-;9$8%+B@4ZM#! !2XHI12* "G 4@IX%(=A,4X#%&*DC7>ZCWI,M*Y./ MW-J3_$U/QK=W"_>CEQ^ XJI MK1CNK>*[A!.X_)Z^R6RO$3F%_O+Z>]98B@W.-6&Z.3# MUTE*E/X601(\DJ1Q*6D<[54=237T59/:^"_!^F:+J%_Y-]=IESGD$\L >P&< M9KSGX1^'XK[7IM;N@!9::I?+#@N1Q^7)JGK6KR>+?&4EV6;R?,VPJ?X8U/'^ M-&(K\D3U\BROZU.4I.R1Z)KN@VEQ8,T$XDC>UDDB7?OPZE22#[C-:'PTOA+I M<]F6R8V#CZ'C^E<(D$L;[HY64@$ @]JLZ/>W>AW9N+-U#D88,,@BN&.+C*:E M8]66"DJ+IIWZGMF*,5YT?'>L!>+:T)]=K?XU)9>/;_SD-Y;0&#.',:D$?K76 MJ\'LSSG@:UKV/0<4TBEBD6:%)4.Y' 8$=P:4BMCB:&$4TBI#3>],00C]ZM9. MM_ZW\:UXO]:*R=;'[S\::$S&Q0!\P^M+0/O#ZTR7N='>?\AFT^G]:IZ^/G_* MKMW_ ,AFT^E4]?\ O_E0MPEL8!'-)3N])5HS-^__ .05IWT7_P!!IV.!3;[_ M )!6G_\ ?\ T&G#H*(;!4W$(IN*>:3%49#"*0BG&D-,0PBFD4\TTTQ#<5=L M)5;=:S8:.08 -4R* 2K CJ*35U8(RY7QZ=_\:Y,CGFE%W*G&VJV&$4TC-24TBKN9G1>&9Q<0W&G2G*LI9?Z MU RLC%'^\IP:S-/NC97\5P,X5OFQZ=ZZ/681'?+*OW9ES^/^2*E:2]2I+F@N MZ.DC^XOT%/ID?W%^@I]1_=ZG^6/QK(\!VC&:[O"/E"B) M3ZD\G^0_.K7CU&-A:/\ PK*0?Q'_ -:O)IQYF)G M*=:3EW"N-\<:8GE1ZE&H#[A'+CN.Q_I^5=E6!XR=4\.RJW5W15^N<_R!J,;" M,J$K]C3 SE'$1Y>KL/\ "'_(M6WU?_T(US/CK_D-P_\ 7NO_ *$U=-X0_P"1 M:MOJ_P#Z$:YOQL-WB"V'K H_\>:N/$_[C'Y';A?]_G\SMM.M5LM-M[9!@1Q@ M'W/<_G5HD $GH**9,I>"1%ZLI _*O42Y8V70\EMRE=]3S>SGMM6\4-=ZC,B6 M^XR8D. 0/NK_ "_(UW7]NZ3_ -!"V_[^"N$\,Z3::M>SV]V9%*)N4(<'K@]O M>NH_X0?2O[]S_P!]C_"O(P3K\CE!)W?4]G'+#^T4)R:LMEL:G]O:3_T$;;_O MX*SM;O-'U32IKZ,<94A5K.=/9A11172WB<95H*$8;<\>H]JUV570JRAE88((R"*\ZMD_LCQRL$!(C\_RP/\ 9;M^&?TK1P>" MG'D=XMVL9*:QT)Z?HS&C_ +G4]5^9H^,;YK31#'&< M/<-Y>1_=ZG_#\:C\':6EKI:WC*#/<P_K5;QZC&RLW_A$C _4C_ZQK=T M&19- L63H(57\0,']12BN?&OFZ+0-=-6VN(=3M MQL:1MK[>/F'(/UX/Y5UNDWAO]*MKH_>D0%OKT/ZYK%\&K,-U(8_@6)%>?27)C)QCLU?YGHUFYX*$I;IV^1S-S-)X;\8RW4L9:" M=F;(_B5CDX]P?Y5V]E?VNH0":UF61#UP>1]1VIM_IUKJ5N8+J(.O4'NI]0>U M<9?^&]0T*0WVEW#O&G)V\.H]QT8?YQ2M5PK;BN:#U\T5>EBXI2?+-:>3.]KE MO&]^UOIL5HAP;ACNQ_=';\R*O>&]>_MFU82J%N8L;P.C#L16%X^1OM%D_P#" M5@_"MJH M+.19K&WE3[KQJP^A%3UUTH1A!1CL<=:>WCDEB^XS#. M*LT5;2>C(4G%W3"N!\.?\CI=?67_ -"KOJX'PY_R.EU]9?\ T*N'%_Q:7J=^ M#_A5?0Z_6KTZ?H]U>:^OKJ%)A\L8D8 \]6_I^ M==)XN1G\-W.W^$H3]-PKG_#?AW3]7TQIYWF$JR%"$8 = 1V]ZRQ//+%145>R MOJ;87V<<))S;5W9V.L_M[2?^@C;?]_!1_;VD_P#01MO^_@K+_P"$'TK^_<_] M]C_"C_A!]*_OW/\ WV/\*WY\7_*OO.?DP?\ -+[C-\82Z9?V<=S;7<#W,38P MC@EE/^!_K6[X6O6OM!@9SEXLQ,?7'3],54_X0?2O[]S_ -]C_"M;2]*M](MF M@MC(49]YWG)S@#^E11I5E7=6:236MBZ]:@\.J4&VT]+G+>/_ /6V'^Z__LM; M_ABP2PT.#"CS)E$KGN2>1^0K \?_ .ML/]U__9:["R&VPM@.T2C]!2HQ3QE2 M7:WY%5YM8*G%=;_F3UD^)8%G\/7@89VIO'L1S6M6?KG_ " ;_P#ZX/\ RKMK M*].2?9G#0;56+7=&/X%E+Z/-&3]R8X^A _\ KT[QK?M:Z2ELAPURV#_NCK_2 MH/ 7_'A=_P#74?RJOX_1MU@_\/SC\?EKSG.2R^Z[?K8])0B\QL^_Z7-CPKI4 M>GZ1'*5'GW"AW;O@]!^5;M5=-D6;3+61/NM$I'Y5:KT*,(PIJ,=CS:\Y3J2E M+>X56N-/M+N:*6XMXY'B.4+#.*LT5HXIJS,U)Q=TPKS47%OJ_BQI[Z9$M0Y/ MSM@;5Z#\>/UKTH\BO,?#NDVVI:K+9WAD4JA(V'!W @8_G7G9AS2E3@NK/3R[ MEC"I-Z67YG>C7=) &H6P _Z:"E_M[2?^@C;?]_!67_P@^E?W[G_ +['^%'_ M @^E?W[G_OL?X5KS8O^5?>8\F#_ )I?<3ZK?:-J>FS6KW]KEERA,@^5NQK& M\"7K>;G8_S%:7_ @^E?W[G_OL?X5E5YK\ M/O\ D/S?]>S?^A+7I5>3DW^ZKU9ZFPJN*M)\EJS=S4,N*U,?59MS;>YK+%6;U]]PWH*K4BEW/&OB%IOV7Q)+*! MA)T$GX]#_*N%ED+2B*(%G)QQVKUWXJ0226%D84!=G9 Q..V<5PO@313?^--. MT^3#&:0-(G=47YFS]0,?C5SGHK'+1PB=1REL=]KBGP3\$[/24?R]0U4[IG'! MP?F;_P =VK7DT-W>:>L4L,CA6R-WK7?_ !@U/^U?&[68.Z#3XUB51TW'YF/Z M@?A7/V5E]K06A95 7=AC^=<];W4G)7/8RR$L35E2IRY4EJ_T'VFO7\;6TIN5 ME&22KC@\< CN*N:!=7%W>Q,\KDB0':3QUK'DLHX^-I6+=@@_PGU'M77^#]'W MR27$K1QQPNJD$\G)ZCUK*,*COJ>XC2=/NHHY);.%F*@D[:S M-1\*PRL!9(D4H./7/\ZZ&# MXPIRNT8/X5)6W)'L>?[6<7HRM96JV M5G%;H25C7:":G-+2&J\C)MMW8TTT]:>>M-/6@01_ZT5DZU_K/QK7C_U@K)UK M_6#ZTQ,QC0/O#ZTII!]X?6J)9TEY_P AFT^G]:I:]][\JNW?_(8M/I_6J>O# MD4HA+J8)ZTE.(I,59F;U]_R"]._X#_Z#3QT%-OO^07I__ ?_ $&GXX%$15-Q MIZTVGD4W%69#:0TXBD(H :132*?2&F(8:;BGD4TTQ,N::X+O _*N.E)K<%HKE1D.N#4;2+6L/0YJ@\TXBFU9F-(KJV M?[;X;@N!R\! ;^7^!KEJZ/PTWGV5[9GD,-P'U&/Z"IGM;V'_ODUBL1B4K>R_$V>'PS=_;?@=3 M>:_I=DA:6\C9A_!&VYC^ KB=1U*]\5:C':VT16('Y(_3_:8UKV_@*(,#[4]V/XLN-7"X;WJ7O2[]$& MEZ='I>GQ6D7.T99O[S=S4>M::-5TJ:UR Y&Z,GLPZ?X?C6A17>Z<>3V=M-CS MU5DI^TOK>YP?AG6_[(GDTS4N=7POX@L"5LKX>7_L3,GYBN&#KX9QV\TT5O$TLTBQQJ,EF. *\Z\3ZT=9GVVRL;.W_BQ]XGC)_I6DGA' M5;Z16U34'P MU12G'%RJ-Z M.YT=%%%>B>8>?ZK#-X9\2K?PIFWE8L!V(/WE_P ^U=M8:C;:E;+/:R!U/4=U M/H1VIUY96]_;-;W,8>-NQ['U'H:Y&?P7>VLYETN^V^FYBC#\1U_2O/Y*N&FW M37-%ZVZH]+VE+$P2JOEFM+]&=M7,^)O$L5E;O:6Z<;2RG/ECOSZUEMX?\ M3W(\N:_.P]=]PQ'Y"M32/!UM8R+/=N+F9>57&$4_3O1.KB*RY(0Y;]6$*6&H MOGJ3YK=$7?#*:@-(1]0E=W?E%?[RKVR>OYULT45VTX?J0OQ#)) 'GGD_[M=Z9HAUE3_OH5R6J>#KF_P!3N+I+J)5E;<%(.15/ M_A KO_G]A_[Y->52>(HN25.]VWN>O66'KJ#=2UDEL=1J/B#3M.A9WN$DD ^6 M*-@6)_I7(^&[:?6?$;:E,/DCV[L!_GM6A:^ D5PUW>EU[I&N,_B?\*ZN MTM(+&W6"VB6.->@'^>:T5*M7J*5962Z&;K4,/3E"B^:4M+D6K?\ (&OO^O>3 M_P!!-0&YL;BW4A3+&R GMD8K*\-Z%+HB7"RS))YI M4C:",8S_ (UK4IR>)A-+17,:56"PLX-ZMHN:WIHU72I;7@.?FC)[,.G^'XUR MGAC7!I4DFEZCF) YVLW_ "S;N#[5W=8VM>&[36/WC9AN ,"51U^H[T8BA-S5 M:E\2_%!AJ\%!T:WPO\&;"LKJ&5@RD9!!R#4=Q<0VL+37$JQQKU9C@5Q \*Z_ M9$K9WP"?],YF3]*D6FD6_E6R< MG[[MRS?6KQ 92" 0>"#WK7#4)0O.H[R>_P#D98K$1J6A35HQV_S*5EK%CJ$\ MT-M.KR1-@CU]QZBK4\\5M \TSA(T&68] *Y/4?!3?:#<:5<"$YR(W)&T^S"J M?_"*Z]>LJ7MZ#$#UDF9\?05E]8Q$;QE3N_+8V6&PTK2C4LNSW%\$J9-:O9XU M*P^61CTRP('Y UT?B723JVE,D8_?Q'?'[GN/Q_PJUI6E6^D68MX 3SEW/5CZ MU>JZ&&Y:'LI]=S.OBN;$>UI]-CB?"OB%+6/^S-0;RMA(C=^ /53ZK,9@3!,&6X(P97ZCZ#M5<^)K-*,> M1=WO]Q/L\-134925"I_&N"T>^D\ M+:U/97H(@<@,P'3T<>W^>U>A5FZOHEIK$(6X4K(OW)5^\O\ B/:GB:$IM5*? MQ1_JPL+7C!.G4^&7X>9?BECGB62)U=&&0RG(-.9E12SL%4#)). *X?\ X1/6 MK!S_ &?J V'^[(T9/U'3]::WA;7[]@M[? I_MRL_Y"H^M5K6]D[_ (?>:?5* M%[^U5OQ^XD\0>(Y;V[BL-'D]9 MVC>'+/1_WBYEN",&5AT^@[5L5IAZ=1-U*KU?3HC+$U:32ITEHNO5G$>/_P#6 MV'^Z_P#[+78V?_'E!_US7^58WB3P_-K;V[13I'Y08'<"G!/57O\ >250US_D W__ %P?^57ZK:A;->:= M<6RL%:6-D!/09%=-1-P:78Y:;2FF^YS?@+_CPN_^NH_E6OXBTHZMI3PICSD. M^//J.WXBH_#FBRZ+;312RI(9'# J",<5M5SX>C_LRI5%T.G$5_\ :75IOJ,8XM2BMK&'[6N[:Y4_>/HOK6>?"VO7Q OM0'E^CRL_Z=*Z M#1_#=EI!\QU<%KMO/X?\1)JENN89'WCTR?O*?KS^?M7?5#=6D%[;/;W$8DB<7+?G8>#NN&Q6"Q->*M.FV_+8W>%H2=X54EY[F MQXC\20Z=;O;6LBO>,-ORG/E^Y]_:I?"BZA_9(DOYG<.D^"[ M>TD6:]D%S(.0@&$!_K74U5&%:=3VM73LO\R:]2C"G[*EKW?^04445VG"%%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >:_#[_D/S?\ M7LW_ *$M>E5YK\/O^0_-_P!>S?\ H2UZ57DY-_NJ]6>IG'^\OT04445ZQY84 M444 )61-_KY/]X_SK8K(F_U\G^\:N!E5V(P*7%***T,4 ZTZDIPI% .E. I! M2TBD*!4URWEVJCVS42C+#ZTNJ-M@_"I9<3G)#ND)]Z04E**0T8/C/2WU7PS< MQ0JIFC_>ID>G.!7(_!#3E;7=7URX&!:0;5W#[I;DG\E/YUVOB'Q#9Z!8F6X) M>5^(X5^\YK!\-//IGPE\2ZM,GES76Z-0!C:NT(!_X]0QI]$>>"&;Q%JFI:I) M((U:1I2S\\D\"M&"RS;B4PE92Y&[':LW0X UNVV20M*VUXCP".U>@:7&C6D- MNT>7BX(8?= KCKUE>Q[F68*>'IJ:T;U./O8_+;RWA!3;C/3)I[S7,=HEZH9! M;R*"!T*DUTNL::DCJR* #U&>]9/B...P\.O&KGS)%7<">.M$/9M+E1KBJM9W M51W1TMKXYNXY(+4;COC&P ],"MR/Q)J,L>Z*X*G^$'U]Z\HLKPKJ^E''^J7> MWN*[U+^U$(F&.F"/>HG.2:29G1HP=-S<=+FH?B!JMI&TD]O#)&APQ;(/7%=+ MH/C33]:986807+2\U9+2 <%L[3P#[FM"VTV]TVXCO'EC!5M MZ[>@-;\TH)<_4EX:A7E:&A]!=J:>M1VLIGM(92,;T5L?45(>M;GC-#HO]8*R M-:_U@^M:\7^L%9&M?ZP?6A$LQZ /F'UI:0?>'UIDG1W?_(8M?I_6JFN_>%7+ MO_D+VOT_K537>HHB$MC!-)BE/6DJR#>O?^09I_\ P'_T&I,<"H[W_D&:?_P' M_P!!J3L*(BGN(128IW:FU1FQI%(13S333)&XII%/I#3$,--(IYIIIB&8JW?1 M_:=!!ZF/_P#558CBK]H/,L+F$^G]/_K5$]BZ>]CB2,$TAJ:==LS#WJ+%40,K M8\,2[-85,_ZQ"O\ 7^E9)%6])?R]6M6_Z: 'Z'C^M$MAQTDF=U:G#RIZ,:LU M5B^6]E'J :M5S'>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% 'FGP^_Y&"?\ Z]6_]"6O2Z\U^'W_ "'YO^O9 MO_0EKTJO*R9WPJ]6>IFZMB7Z(****]4\L**** "LF4?OY/\ >-:U94H_?2?[ MQJX&578912XH JS(*444H%(8M+2 4HH*'Q\NOU%0:RV(\>U6(_\ 6+]:J:U] MW%0RUL8=+2=Z6@9Y7J-O?7&O7]SJ"Q_:MWE0HQRLD?R6JWC-(;2Z@N2X5IALQZD=ZO>+6(^$.FL.C3*3CZL:XZ+J?690G\ M+V+Q7*L/SP^))GG.EW!TZ6/[9&3$5V+.JY4CW]#7;Z==1SQLR7,3J6W*8W!K ME;>#4+G1XI"K?88I-ID SM/7K5Z73;18VFF$ 55RTX)0GW..,UE7H6DTSV\% MC)U:$9[IHOZC?0F1WE>-!'GOM!^M1>'[31O%]X;"\NY8OFS&%& Y^IK@M1FA MFDD@MER6?:,DDA?7FMO3H)M-:UGC!1N&4GL:JG35.TI'5[1XJ,J<--/Q/4[? MX0Z9;W9G&HW3 C&"J\#TKH[3P3HEJJ[K9L_I5;PEXLCUF'[+=.@O8QS M@_?'K755V)1O='A5*E:'[N3L>(>/M/M(_% 73;:&U%H@#,@^^YYY'L,5E0SW MLGDQW6V1)F$9C"X*@]&%;/BEA;>,M1$X/S2[E'J"!C]/Y4ND6\>JZO:PJ^W1C&.&YHZ.VY[+!&L-O%$HPJ(% ]@*=FBBNX^;;N[CH MO]8*R=:_U@^M:T7^L%9.M?ZP?6@3,B@?>'UHH'WA]:9)T=W_ ,A>U^G]:J:[ MU%6[O_D+VOT_K537>HHB$MC"[TE+WI*H@W;W_D&:?_P'_P!!J4=!4=[_ ,@S M3_\ @/\ Z#4HZ"B(I[B$4W%.-)5D,:12$4ZD(IDC:0T[%-(H$---Q3R*3%,D M8:O:9]^5?5:IXJYIO_'PW^[2EL73^)'+7Z;+MQ[U4K1U5<7C_4U0Q0B6,(J2 MV.RZB8=0X/ZTREBXF0_[0IO8%N=^3MOU]TJW5)_^/Z'_ '*NUS'>%%%% !11 M10 445GZU>2V.F27$.-ZD8R,BFE=V1,Y*$7)]#0HKE+74?$5[;"X@CA>,Y . M #Q[9J:S\2S1W8M=4M_);LV:F^55N,G<%QCKQ1.%ET"C5WNXED1@1R.1]*-4\*_;?A[9:+#I^#KGPAJS"[@:6UW92X[,O^ M>U:MA=:>CN]P %L:U/F6A[& K4W-0G+E16EA^QWD-[:;H]F6WJ<97T_"O4 M/"GBN'6X?L\K@7B#D$8W#UKQRTU(7T*6K39PN% /-5Y]9FT:\2>.0I-&04=> MI]L5S4ZDH2Y3U\1@:=>DW.2377^OQ.T^(T2IXHCN$<,)H0.#T*D@U:^']JKZ M^')YBB9OQ/']:\_N_%<>N>(6GE0V\,@^52V0KDY+>V3R?>O2OA\%75Y\.K9A MR"#GO1*'^T)GF*?^PM=4>DTE&:3->@>&Q\7^L%96M?ZP?6M6+_6"LK6O]8/K M2![&12#[P^M+0/O#ZTT2='=_\A>U^G]:J:[U%6[O_D+VOT_K537>HH02,(]: M*4TE6B#=O?\ D&:?_P !_P#0:F'05#>_\@W3_P#@/_H-3=A2B$]Q#24ZDJR! MM(:=2$4"&TAIV*0BF2,-)3R*;B@D::N:;_KW/HM5,5=TX8\UO04I?"73^)'- MZM_Q]-]36?5[4CNN#5(BF2QA%.C'[Y!_M"@BI+9"]W"OJX'ZT=!+<[:7_C_A M'^S5ZJ+G.IJ/1:O5SG>%%%% !1110 5D>)O^0'-]1_.M>LCQ*"=#F &>1_.K MI_&C'$?P9>C&>%?^0%%_OM_.J/C.-/LUM)CYPY7/MBJ6D^(?[-T];4V;R,I) MW;L=3]*>\&I>);N-YH3!:IZC&!W^IKI4'&HYO1'G.M&IAE1AK*R+]_J+6_A6 M EOWL\80>O3G]*R;C2XX?#4$ZLOVE6\QL'G!_P BK&H1?VKK\.G1AEMK<;'))-/U2YTV7(4D[?J/\12>%U(UF]R M#@J>H_VJ2BHUA;RV4M;2G!4?J*E\62K=6-E+%ED8D@@>U4M9Q:V(EI1JJ?Q]?T"UO M?$2VL2Q6431!0%)'4?G74QEC$A<8<@;A[URMMXK6WM8H38R$HH7.[KC\*Z'3 M;X:C9) MK/4SC_>7Z(****]8\L**** "LV0?OG_WC6E6M_O&JB1/8;BC%*1BDJS, M**6@4@ "EH R:7&*!V <&HM97=;AO:I<&EOUWV&?2I92V.9HHHH *V--_>Z9 MB2[+MHSTD7]12&C0MFW0*?:IJ@MQL#QG^!B*GH ,TC .I5@" MI&"#T-+13&>=Z[\.+2&\?5M'A82\E[92 #G^[_A7FGB:.VNXH70XF5BK1'@@ M]/PKZ/KS'XC^%[/SEU:.)$:0[9#T&X=#6-6*^-[H]'!5N:]"3]UGB%U:3V4Q M26)XR#QN%:NE:K=6%S%5N$O4A@,UYU$/(< M,._4&LZ=15/5'14I+#5+7O%GU582RR6T8F=7D$2$NO0DC_ZU6JQ/"5Y#?>%M M/GA<,/)5&/?*C'-;==3/'F_>8^+_ %@K+UK_ %@^M:D7^M6LK6O]8/K02]C) MH'WA]:*!]X?6F*YT=W_R%[7Z?UJKK@R15J[_ .0O:_3^M5=K MG-RWM58BIICNF8^]1FJ(&$5=TB/S-6ME]'W?D,U3K8\.1;]1,A'$:$_B>*3> M@XJ[-^/Y]3D/]T 5?K/L#YD\TGJW%:%8'8%%%% !1110 4444 &!Z4444 &* M*** #%&*** "C HHH ,#THHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S7X??\ M(?F_Z]F_]"6O2J\U^'W_ "'YO^O9O_0EKTJO)R;_ '5>K/4SC_>7Z(****]8 M\L**** "L]_]:WU-7ZRTNHIKF:,'#HQ!![\U42)O8EV@CCK3T0,.:8#3@<'B MGI#G'%-B/SD'O0*UCE)5VR,/>FUAYJG3)"I;:7R+F.7^ZW/ MTJ*B@9TTH"W6\?=D7/XTZJUG+]ITU>@(S\PYK6H/(Q2:OH.,G%W1XTNHD69B@.6?@D#I7'77AJXOKZ1-( M!G<*9&A'!]R/7Z5TWB:*Z\+>*IH%CWV=PQEAW< (3]T'V/%0:1J,MOK\.IJB MQF-]Q11P4[C\LUR4Z3I5-=F?15)T\3A?=W1W/PILM2L=!N8[Z&2&,RYA208/ M3YC_ "KO:;&ZR1JZ''UI*4?>'UIDG1W?\ R%[7Z?UJKKG45:N_^0O:_0_SJKKG44D5+8PC MUHHHJC-F[>#_ (EMA_P'_P!!J<=!4%Y_R#;#_@/_ *#4XZ"B(3"DI:*HD;12 MTE A*0BG4E,0VDQ3B*3% F.AC\R55]33=8GVJ5_NC%6[1=BM,W;@5A:K-O?& M>25D9E8$!Q5^Y)%K,0<$(?Y M5FV3*_B&_=2"IBC(([\5I77_ !Z3?[C?RJ9?$OD:TG[C]7^;,S3;2._T6S:X M>5F"'E964GGO@\U6FT^%-=M[97N/*>)F8>>_4?C6AH/_ " [3_<_J:AN/^1G MM/\ K@U6I/F:]3%PBZ4&UK[I=MM.@M)"\1EW$8^>5F'Y$UAW-].-5.H([?8H M9! P!X.>I_.MG5KS[#ILTP^_C"#U)Z5D076FKHGV!Y9"60[CY3?>/.>GK13N M_>>O0*[BFH1=K:_/H='G*Y%9>@.\EE*79F(G<9)SWHT&\^UZ4@8YEB^1\^W3 M]*;X=_X\9O\ KX?^=2X\JDF:*:G.$EU3_0NZFQ72[IE)!$3$$=N*32V+:5:L MQ))C&23UXHU3_D%7?_7)OY57M;E;3P[#&[H26;VQ8LT#;02,97MUJZD?=VV,*%5<^]^;7T_I?D5+;4IK36+OSV)L MWF\O<3G8W;Z"M^[)%E.0<$1L01]*R;"VCNWU:"5O;_(TM)9GTFU9B2QB!))R3Q5RJ6D?\ M@>T_ZY+_ "J[64OB9U4O@CZ&3(['Q-'%O;8;9LJ#QUIM[I-M#93RHUP'5"0? M/?KCZTK_ /(UQ?\ 7LW\ZNZC_P @VY_ZY-_*KNTXV.=1C)3YE?5_D9VFZ7;W M&G6\TKW!=T!8^>XY_.MI%"(JC. ,#)S5+1_^0/:?]W6L0_P 192A]& XJ[#JH_L,WD@_> M1J59?]L<8_.KFKVMY&-"?)S*6VK_ !U*%_>2RZ_:QQ.P@BE"-@\,Q&2*L7<( MNO$B02/*(OL^[:DA7G/L:KO:M:1Z2LG,KW.^0^K$&IKN.:7Q.BPSF%OLWWMH M;O[U>G3LS+5WYE>[6GZ%Y-'M8W5U,^5.1F=S_6KDTJ00O*YPJ DFJ]O;W<4N MZ:],R8^[Y87]16=XBND6*&S9BHF<%R 20@Z]*R2*CNK*2:QM;NUXNX$4H?[PQRIJ">]COY-)F3@^ M>0RGJIQR*$DY%#LS]T*!_C6_3=B9)VKD]3CK6<9 M)7N;U(.5K.UC.T&5)M(B=-Y))WENI;O1JNE2ZC)&T=Y)!L!!"$\UI*JJ,* ! MZ 4M/G:ES(7LDZ:A+4X*_MKJRU:*R%_.P?;\V\\9/UK>M]&DTZ87%:DJD]9/KV,7P]K#ZE \<^//BZD?Q#UK8FE2"%Y M7.$0$DUR'A<%]=N9(QB+:WZGBNAUY6;0[L)UV?U&:FI!*I9&F&K2>'2!9C!:IU"G@#M]35QO"CVZ[[*^D24#C/ /Y5+X.9#IDJC&\2Y; M\ABGZOJ^IZ?-(T=G&UJF/WC ]_Q]:TE*7/R0T.>%.DZ*K5;MOKKH3:HUQ#X8 MG M#5+X3&=$P>GF-_2I5XP;ZIEM*I644]'$=X8OS>::8Y&+2PMM.3R1V-5/$][, M;BVT^V=ED<[FV'!YX JI;.-!\3R1.=MO+GD]@>1^M2:(C:IX@N-1?[D9^7/K MT'Z57*HR=3IN0JLITU0^U>S]$+XF\VQL["**:0%00S!SECQUJ:+PYPI0OB)KE M]<]-P3AR+L<_-!<";1T\V3S5 \Q 3R .2:Z"BBB4N85.GR7\PHHHJ30**** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@#S7X??\A^;_ *]F_P#0EKTJO-?A]_R'YO\ KV;_ -"6O2J\ MG)O]U7JSU,X_WE^B"BBBO6/+"BBB@ -<9OLC?L;C[1;*S$;APU7 F5S7(B5E'!(SUP:E6XD*X+L1]:;@1 M&KIJ=/DCB@$BL*+49XT"\,!_>J<:NW>)3^-+D9:JQ-E)#T-35C1:JI_UD97Z M&K4>J0G (8>]2XLTC-/J7Z;MQ\WH:%8.H93D'H:<*@LS=9@WQK*![&L&NNFC M\ZW>,]QQ7+31^7(5/4&FA-$5%+24R2_I5QY%WAC\CC:?K6QL\MV3MU'TKF:Z M&RN/MEH!G][%P?>D-$U%*.113 2BEI0I(H Y[Q;X>77]**H%%Y#\\#D=#Z'V M.*\DBLKAKYVO0L*,3(.K#U^M88B,I0] MS<]' 5E"?)/9FGX.U%;S1UMB?WEL F#_ '>U=%7D>E:H^E7\5W$WRGAUSPXK MU2RO8-0M4N+=PR.,CV]12PU;VD==R,?A71J.2V9:A_UHK+UK_6_C6K#_ *T5 ME:T/WGXUT=3AZ&30/O#ZT4#J/K3)1T=W_P A:U^A_G577.U6KK_D+6OT/\ZJ MZYVI( M9,S>]:FJ71;*@\FL?%"T!ZL;13J2F(M:9;_:K^-",J#N;Z"K]])]KU@@F20P+ND8C R!WJ_133L[DSBIQ<7U,Z[M9I;K3G1XIU%#;=A*"3;[F-I&E3:=J%T2=T#*HB8G)QZ?A6K. MI>WD11EF0@?E4E%.4G)W8H4HPCRQV*6DV\EKI5O!,NV1%PPSG'-1S6LSZ[;W M*K^Z2)E9LC@FM&BCF=V^X>S7*H]K?@9UY:S7>I6H9/\ 1829&.1RW88K1HHI M-WT*C!)M]S,BLYK;6YIHUS;7"9?D?*X]JJZ>NI:?%)$-/\P&5G#"91P3]:W: M*KG>S1G[!7NFUO\ B9LC7MY974,EEY):(A,R*2PNIK'3K)H\1)M-Q M\PZ#M[UM44*;6P.BI?$VPP/2LV6TFCUN*\@3='(ACF&0,>AK2HJ4[&DH*5KF M?IMK-;W%\\JX66;Q ME&2YTO0(2(5>6)%#*6Z>M:@Y -,EACG"B1=P5@P!]14E#=RH1<7:^FAG/:S' MQ!'=!?W(@*%LCKGTJU>QM-8SQH,NR$ >^*GHHYGIY J:2:[E7389+?3;>&48 M=$ 89S@U:HHI-W=RHQY4DC/LK6:'4KZ9UPDK*4.1S@52DTBX;6<@C[ SB=QG M^,=L?K6[15*HT[F3H1:2?1W,_4K6:XN+%XER(IM[\@8&*@NX;R/6UO+>U\Y! M#L/SA><^]:]%"FT.5%2;=_/[C/CN]0:10^F%5)Y;SE.*2VM)FU:XO+A,<".$ M9!^7N?Q-:-%+F[(?L]KMNWH(RAE*L 01@BL2/3[N/1[VP$>1EA =P^93V]JW M**(R:"=-3W_JY%;HT=M$C##*@!'X5D7.C.-:M[RV_P!5YFZ5,X /K6Y11&;B M[H)THS23Z&?<3ZC;7+LML+BV;&T(<.OY]:KO'=ZK

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end GRAPHIC 4 darecorporatepresentatio002.jpg GRAPHIC begin 644 darecorporatepresentatio002.jpg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ƿ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